
1: Zhou JX, Yang X, Ning S, Wang L, Wang K, Zhang Y, Yuan F, Li F, Zhuo DD, Tang 
L, Zhuo D. Identification of KANSARL as the first cancer predisposition fusion
gene specific to the population of European ancestry origin. Oncotarget. 2017 Mar
24;8(31):50594-50607. doi: 10.18632/oncotarget.16385. eCollection 2017 Aug 1.
PubMed PMID: 28881586; PubMed Central PMCID: PMC5584173.


2: Polak P, Kim J, Braunstein LZ, Karlic R, Haradhavala NJ, Tiao G, Rosebrock D, 
Livitz D, Kübler K, Mouw KW, Kamburov A, Maruvka YE, Leshchiner I, Lander ES,
Golub TR, Zick A, Orthwein A, Lawrence MS, Batra RN, Caldas C, Haber DA, Laird
PW, Shen H, Ellisen LW, D'Andrea AD, Chanock SJ, Foulkes WD, Getz G. A mutational
signature reveals alterations underlying deficient homologous recombination
repair in breast cancer. Nat Genet. 2017 Oct;49(10):1476-1486. doi:
10.1038/ng.3934. Epub 2017 Aug 21. PubMed PMID: 28825726.


3: Yates LR, Knappskog S, Wedge D, Farmery JHR, Gonzalez S, Martincorena I,
Alexandrov LB, Van Loo P, Haugland HK, Lilleng PK, Gundem G, Gerstung M,
Pappaemmanuil E, Gazinska P, Bhosle SG, Jones D, Raine K, Mudie L, Latimer C,
Sawyer E, Desmedt C, Sotiriou C, Stratton MR, Sieuwerts AM, Lynch AG, Martens JW,
Richardson AL, Tutt A, Lønning PE, Campbell PJ. Genomic Evolution of Breast
Cancer Metastasis and Relapse. Cancer Cell. 2017 Aug 14;32(2):169-184.e7. doi:
10.1016/j.ccell.2017.07.005. PubMed PMID: 28810143; PubMed Central PMCID:
PMC5559645.


4: Feng YA, Cho K, Lindstrom S, Kraft P, Cormack J; IGAP Consortium, Colorectal
Transdisciplinary Study (CORECT); Discovery, Biology, and Risk of Inherited
Variants in Breast Cancer (DRIVE); Elucidating Loci Involved in Prostate Cancer
Susceptibility (ELLIPSE); Transdisciplinary Research in Cancer of the Lung
(TRICL), Liang L, Driver JA. Investigating the genetic relationship between
Alzheimer's disease and cancer using GWAS summary statistics. Hum Genet. 2017 Aug
5. doi: 10.1007/s00439-017-1831-6. [Epub ahead of print] PubMed PMID: 28780673.


5: Chan CHT, Munusamy P, Loke SY, Koh GL, Wong ESY, Law HY, Yoon CS, Tan MH, Yap 
YS, Ang P, Lee ASG. Identification of Novel Breast Cancer Risk Loci. Cancer Res. 
2017 Oct 1;77(19):5428-5437. doi: 10.1158/0008-5472.CAN-17-0992. Epub 2017 Aug 3.
PubMed PMID: 28775167.


6: Velmurugan KR, Varghese RT, Fonville NC, Garner HR. High-depth, high-accuracy 
microsatellite genotyping enables precision lung cancer risk classification.
Oncogene. 2017 Jul 31. doi: 10.1038/onc.2017.256. [Epub ahead of print] PubMed
PMID: 28759038.


7: Li Y, Steppi A, Zhou Y, Mao F, Miller PC, He MM, Zhao T, Sun Q, Zhang J.
Tumoral expression of drug and xenobiotic metabolizing enzymes in breast cancer
patients of different ethnicities with implications to personalized medicine. Sci
Rep. 2017 Jul 6;7(1):4747. doi: 10.1038/s41598-017-04250-2. PubMed PMID:
28684774; PubMed Central PMCID: PMC5500564.


8: Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ,
Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA,
Easton DF, Antoniou AC, BRCA1 and BRCA2 Cohort Consortium, McGuffog L, Evans DG, 
Barrowdale D, Frost D, Adlard J, Ong KR, Izatt L, Tischkowitz M, Eeles R,
Davidson R, Hodgson S, Ellis S, Nogues C, Lasset C, Stoppa-Lyonnet D, Fricker JP,
Faivre L, Berthet P, Hooning MJ, van der Kolk LE, Kets CM, Adank MA, John EM,
Chung WK, Andrulis IL, Southey M, Daly MB, Buys SS, Osorio A, Engel C, Kast K,
Schmutzler RK, Caldes T, Jakubowska A, Simard J, Friedlander ML, McLachlan SA,
Machackova E, Foretova L, Tan YY, Singer CF, Olah E, Gerdes AM, Arver B, Olsson
H. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 
Mutation Carriers. JAMA. 2017 Jun 20;317(23):2402-2416. doi:
10.1001/jama.2017.7112. PubMed PMID: 28632866.


9: Abu-Jamous B, Buffa FM, Harris AL, Nandi AK. In vitro downregulated hypoxia
transcriptome is associated with poor prognosis in breast cancer. Mol Cancer.
2017 Jun 15;16(1):105. doi: 10.1186/s12943-017-0673-0. PubMed PMID: 28619028;
PubMed Central PMCID: PMC5472949.


10: Fan J, Wu Y, Yuan M, Page D, Liu J, Ong IM, Peissig P, Burnside E.
Structure-Leveraged Methods in Breast Cancer Risk Prediction. J Mach Learn Res.
2016 Dec;17. pii: 85. PubMed PMID: 28559747; PubMed Central PMCID: PMC5446896.


11: Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS,
Whalen S, Sarkar AK, Albrecht E, Altmaier E, Amini M, Barbieri CM, Boutin T,
Campbell A, Demerath E, Giri A, He C, Hottenga JJ, Karlsson R, Kolcic I, Loh PR, 
Lunetta KL, Mangino M, Marco B, McMahon G, Medland SE, Nolte IM, Noordam R,
Nutile T, Paternoster L, Perjakova N, Porcu E, Rose LM, Schraut KE, Segrè AV,
Smith AV, Stolk L, Teumer A, Andrulis IL, Bandinelli S, Beckmann MW, Benitez J,
Bergmann S, Bochud M, Boerwinkle E, Bojesen SE, Bolla MK, Brand JS, Brauch H,
Brenner H, Broer L, Brüning T, Buring JE, Campbell H, Catamo E, Chanock S,
Chenevix-Trench G, Corre T, Couch FJ, Cousminer DL, Cox A, Crisponi L, Czene K,
Davey Smith G, de Geus EJCN, de Mutsert R, De Vivo I, Dennis J, Devilee P,
Dos-Santos-Silva I, Dunning AM, Eriksson JG, Fasching PA, Fernández-Rhodes L,
Ferrucci L, Flesch-Janys D, Franke L, Gabrielson M, Gandin I, Giles GG, Grallert 
H, Gudbjartsson DF, Guénel P, Hall P, Hallberg E, Hamann U, Harris TB, Hartman
CA, Heiss G, Hooning MJ, Hopper JL, Hu F, Hunter DJ, Ikram MA, Im HK, Järvelin
MR, Joshi PK, Karasik D, Kellis M, Kutalik Z, LaChance G, Lambrechts D,
Langenberg C, Launer LJ, Laven JSE, Lenarduzzi S, Li J, Lind PA, Lindstrom S, Liu
Y, Luan J, Mägi R, Mannermaa A, Mbarek H, McCarthy MI, Meisinger C, Meitinger T, 
Menni C, Metspalu A, Michailidou K, Milani L, Milne RL, Montgomery GW, Mulligan
AM, Nalls MA, Navarro P, Nevanlinna H, Nyholt DR, Oldehinkel AJ, O'Mara TA,
Padmanabhan S, Palotie A, Pedersen N, Peters A, Peto J, Pharoah PDP, Pouta A,
Radice P, Rahman I, Ring SM, Robino A, Rosendaal FR, Rudan I, Rueedi R, Ruggiero 
D, Sala CF, Schmidt MK, Scott RA, Shah M, Sorice R, Southey MC, Sovio U, Stampfer
M, Steri M, Strauch K, Tanaka T, Tikkanen E, Timpson NJ, Traglia M, Truong T,
Tyrer JP, Uitterlinden AG, Edwards DRV, Vitart V, Völker U, Vollenweider P, Wang 
Q, Widen E, van Dijk KW, Willemsen G, Winqvist R, Wolffenbuttel BHR, Zhao JH,
Zoledziewska M, Zygmunt M, Alizadeh BZ, Boomsma DI, Ciullo M, Cucca F, Esko T,
Franceschini N, Gieger C, Gudnason V, Hayward C, Kraft P, Lawlor DA, Magnusson
PKE, Martin NG, Mook-Kanamori DO, Nohr EA, Polasek O, Porteous D, Price AL,
Ridker PM, Snieder H, Spector TD, Stöckl D, Toniolo D, Ulivi S, Visser JA, Völzke
H, Wareham NJ, Wilson JF; LifeLines Cohort Study; InterAct Consortium;
kConFab/AOCS Investigators; Endometrial Cancer Association Consortium; Ovarian
Cancer Association Consortium; PRACTICAL consortium, Spurdle AB, Thorsteindottir 
U, Pollard KS, Easton DF, Tung JY, Chang-Claude J, Hinds D, Murray A, Murabito
JM, Stefansson K, Ong KK, Perry JRB. Genomic analyses identify hundreds of
variants associated with age at menarche and support a role for puberty timing in
cancer risk. Nat Genet. 2017 Jun;49(6):834-841. doi: 10.1038/ng.3841. Epub 2017
Apr 24. PubMed PMID: 28436984.


12: Brown D, Smeets D, Székely B, Larsimont D, Szász AM, Adnet PY, Rothé F, Rouas
G, Nagy ZI, Faragó Z, Tőkés AM, Dank M, Szentmártoni G, Udvarhelyi N, Zoppoli G, 
Pusztai L, Piccart M, Kulka J, Lambrechts D, Sotiriou C, Desmedt C. Phylogenetic 
analysis of metastatic progression in breast cancer using somatic mutations and
copy number aberrations. Nat Commun. 2017 Apr 20;8:14944. doi:
10.1038/ncomms14944. Erratum in: Nat Commun. 2017 Jun 06;8:15759. PubMed PMID:
28429735; PubMed Central PMCID: PMC5474888.


13: Stoll RJ, Thompson GR, Samy MD, Blanck G. De novo, systemic, deleterious
amino acid substitutions are common in large cytoskeleton-related protein coding 
regions. Biomed Rep. 2017 Feb;6(2):211-216. doi: 10.3892/br.2016.826. Epub 2016
Dec 8. PubMed PMID: 28357075; PubMed Central PMCID: PMC5351269.


14: Atshemyan S, Chavushyan A, Berberian N, Sahakyan A, Zakharyan R, Arakelyan A.
Characterization of BRCA1/2 mutations in patients with family history of breast
cancer in Armenia. F1000Res. 2017 Jan 10;6:29. doi:
10.12688/f1000research.10434.1. eCollection 2017. PubMed PMID: 28357044; PubMed
Central PMCID: PMC5357036.


15: Subramanian S, Chaparala S, Avali V, Ganapathiraju MK. A pilot study on the
prevalence of DNA palindromes in breast cancer genomes. BMC Med Genomics. 2016
Dec 5;9(Suppl 3):73. doi: 10.1186/s12920-016-0232-3. PubMed PMID: 28117658;
PubMed Central PMCID: PMC5260791.


16: Fkih M'hamed I, Privat M, Trimeche M, Penault-Llorca F, Bignon YJ, Kenani A. 
miR-10b, miR-26a, miR-146a And miR-153 Expression in Triple Negative Vs Non
Triple Negative Breast Cancer: Potential Biomarkers. Pathol Oncol Res. 2017 Jan
18. doi: 10.1007/s12253-017-0188-4. [Epub ahead of print] PubMed PMID: 28101798.


17: Shi Y, Steppi A, Cao Y, Wang J, He MM, Li L, Zhang J. Integrative Comparison 
of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans 
with Implications for Precision Medicine. Cancer Res. 2017 Jan 15;77(2):423-433. 
doi: 10.1158/0008-5472.CAN-16-1959. Epub 2016 Nov 15. PubMed PMID: 28069798;
PubMed Central PMCID: PMC5243181.


18: Zhu L, Ding Y, Chen CY, Wang L, Huo Z, Kim S, Sotiriou C, Oesterreich S,
Tseng GC. MetaDCN: meta-analysis framework for differential co-expression network
detection with an application in breast cancer. Bioinformatics. 2017 Apr
15;33(8):1121-1129. doi: 10.1093/bioinformatics/btw788. PubMed PMID: 28031185.


19: Wang W, Zhang H, Wang X, Patterson J, Winter P, Graham K, Ghosh S, Lee JC,
Katsetos CD, Mackey JR, Tuszynski JA, Wong GK, Ludueña RF. Novel mutations
involving βI-, βIIA-, or βIVB-tubulin isotypes with functional resemblance to
βIII-tubulin in breast cancer. Protoplasma. 2017 May;254(3):1163-1173. doi:
10.1007/s00709-016-1060-1. Epub 2016 Dec 9. PubMed PMID: 27943021.


20: Ruiz-Narváez EA, Lunetta KL, Hong CC, Haddad S, Yao S, Cheng TD, Bensen JT,
Bandera EV, Haiman CA, Troester MA, Ambrosone CB, Rosenberg L, Palmer JR. Genetic
variation in the insulin, insulin-like growth factor, growth hormone, and leptin 
pathways in relation to breast cancer in African-American women: the AMBER
consortium. NPJ Breast Cancer. 2016;2. pii: 16034. Epub 2016 Oct 26. PubMed PMID:
27942580; PubMed Central PMCID: PMC5142758.


21: Zhang Y, Wagner EK, Guo X, May I, Cai Q, Zheng W, He C, Long J. Long
intergenic non-coding RNA expression signature in human breast cancer. Sci Rep.
2016 Nov 29;6:37821. doi: 10.1038/srep37821. PubMed PMID: 27897201; PubMed
Central PMCID: PMC5126689.


22: Rebbeck TR, Friebel TM, Mitra N, Wan F, Chen S, Andrulis IL, Apostolou P,
Arnold N, Arun BK, Barrowdale D, Benitez J, Berger R, Berthet P, Borg A, Buys SS,
Caldes T, Carter J, Chiquette J, Claes KB, Couch FJ, Cybulski C, Daly MB, de la
Hoya M, Diez O, Domchek SM, Nathanson KL, Durda K, Ellis S; EMBRACE, Evans DG,
Foretova L, Friedman E, Frost D, Ganz PA, Garber J, Glendon G, Godwin AK, Greene 
MH, Gronwald J, Hahnen E, Hallberg E, Hamann U, Hansen TV; HEBON, Imyanitov EN,
Isaacs C, Jakubowska A, Janavicius R, Jaworska-Bieniek K, John EM, Karlan BY,
Kaufman B, Investigators K, Kwong A, Laitman Y, Lasset C, Lazaro C, Lester J,
Loman N, Lubinski J, Manoukian S, Mitchell G, Montagna M, Neuhausen SL,
Nevanlinna H, Niederacher D, Nussbaum RL, Offit K, Olah E, Olopade OI, Park SK,
Piedmonte M, Radice P, Rappaport-Fuerhauser C, Rookus MA, Seynaeve C, Simard J,
Singer CF, Soucy P, Southey M, Stoppa-Lyonnet D, Sukiennicki G, Szabo CI,
Tancredi M, Teixeira MR, Teo SH, Terry MB, Thomassen M, Tihomirova L, Tischkowitz
M, Toland AE, Toloczko-Grabarek A, Tung N, van Rensburg EJ, Villano D,
Wang-Gohrke S, Wappenschmidt B, Weitzel JN, Zidan J, Zorn KK, McGuffog L, Easton 
D, Chenevix-Trench G, Antoniou AC, Ramus SJ. Inheritance of deleterious mutations
at both BRCA1 and BRCA2 in an international sample of 32,295 women. Breast Cancer
Res. 2016 Nov 11;18(1):112. PubMed PMID: 27836010; PubMed Central PMCID:
PMC5106833.


23: Zhu Q, Shepherd L, Lunetta KL, Yao S, Liu Q, Hu Q, Haddad SA,
Sucheston-Campbell L, Bensen JT, Bandera EV, Rosenberg L, Liu S, Haiman CA,
Olshan AF, Palmer JR, Ambrosone CB. Trans-ethnic follow-up of breast cancer GWAS 
hits using the preferential linkage disequilibrium approach. Oncotarget. 2016 Dec
13;7(50):83160-83176. doi: 10.18632/oncotarget.13075. PubMed PMID: 27825120;
PubMed Central PMCID: PMC5341253.


24: Infante JR, Hollebecque A, Postel-Vinay S, Bauer TM, Blackwood EM,
Evangelista M, Mahrus S, Peale FV, Lu X, Sahasranaman S, Zhu R, Chen Y, Ding X,
Murray ER, Schutzman JL, Lauchle JO, Soria JC, LoRusso PM. Phase I Study of
GDC-0425, a Checkpoint Kinase 1 Inhibitor, in Combination with Gemcitabine in
Patients with Refractory Solid Tumors. Clin Cancer Res. 2017 May
15;23(10):2423-2432. doi: 10.1158/1078-0432.CCR-16-1782. Epub 2016 Nov 4. PubMed 
PMID: 27815358.


25: Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, 
Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A,
Barjhoux L, Barrowdale D, Benitez J, Berthet P, Blok MJ, Bobolis K, Bonadona V,
Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caligo MA, Chiquette J,
Chung WK, Claes KB, Daly MB, Damiola F, Davidson R, De la Hoya M, De Leeneer K,
Diez O, Ding YC, Dolcetti R, Domchek SM, Dorfling CM, Eccles D, Eeles R, Einbeigi
Z, Ejlertsen B; EMBRACE, Engel C, Gareth Evans D, Feliubadalo L, Foretova L,
Fostira F, Foulkes WD, Fountzilas G, Friedman E, Frost D, Ganschow P, Ganz PA,
Garber J, Gayther SA; GEMO Study Collaborators, Gerdes AM, Glendon G, Godwin AK, 
Goldgar DE, Greene MH, Gronwald J, Hahnen E, Hamann U, Hansen TV, Hart S, Hays
JL; HEBON, Hogervorst FB, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L, Jakubowska 
A, James P, Janavicius R, Jensen UB, John EM, Joseph V, Just W, Kaczmarek K,
Karlan BY; KConFab Investigators, Kets CM, Kirk J, Kriege M, Laitman Y, Laurent
M, Lazaro C, Leslie G, Lester J, Lesueur F, Liljegren A, Loman N, Loud JT,
Manoukian S, Mariani M, Mazoyer S, McGuffog L, Meijers-Heijboer HE, Meindl A,
Miller A, Montagna M, Mulligan AM, Nathanson KL, Neuhausen SL, Nevanlinna H,
Nussbaum RL, Olah E, Olopade OI, Ong KR, Oosterwijk JC, Osorio A, Papi L, Park
SK, Pedersen IS, Peissel B, Segura PP, Peterlongo P, Phelan CM, Radice P, Rantala
J, Rappaport-Fuerhauser C, Rennert G, Richardson A, Robson M, Rodriguez GC,
Rookus MA, Schmutzler RK, Sevenet N, Shah PD, Singer CF, Slavin TP, Snape K,
Sokolowska J, Sønderstrup IM, Southey M, Spurdle AB, Stadler Z, Stoppa-Lyonnet D,
Sukiennicki G, Sutter C, Tan Y, Tea MK, Teixeira MR, Teulé A, Teo SH, Terry MB,
Thomassen M, Tihomirova L, Tischkowitz M, Tognazzo S, Toland AE, Tung N, van den 
Ouweland AM, van der Luijt RB, van Engelen K, van Rensburg EJ, Varon-Mateeva R,
Wappenschmidt B, Wijnen JT, Rebbeck T, Chenevix-Trench G, Offit K, Couch FJ, Nord
S, Easton DF, Antoniou AC, Simard J. Association of breast cancer risk in BRCA1
and BRCA2 mutation carriers with genetic variants showing differential allelic
expression: identification of a modifier of breast cancer risk at locus 11q22.3. 
Breast Cancer Res Treat. 2017 Jan;161(1):117-134. doi: 10.1007/s10549-016-4018-2.
Epub 2016 Oct 28. PubMed PMID: 27796716; PubMed Central PMCID: PMC5222911.


26: Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der
Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, van 
de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, Martin S, Davies
HR, Debets R, Gelder ME, van Deurzen CH, MacGrogan G, Van den Eynden GG, Purdie
C, Thompson AM, Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt
C, Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal PA,
Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen-Dale AL, Birney E,
Stunnenberg HG, Stratton M, Foekens JA, Martens JW. Breast cancer genome and
transcriptome integration implicates specific mutational signatures with immune
cell infiltration. Nat Commun. 2016 Sep 26;7:12910. doi: 10.1038/ncomms12910.
PubMed PMID: 27666519; PubMed Central PMCID: PMC5052682.


27: Van Grembergen O, Bizet M, de Bony EJ, Calonne E, Putmans P, Brohée S, Olsen 
C, Guo M, Bontempi G, Sotiriou C, Defrance M, Fuks F. Portraying breast cancers
with long noncoding RNAs. Sci Adv. 2016 Sep 2;2(9):e1600220. doi:
10.1126/sciadv.1600220. eCollection 2016 Sep. PubMed PMID: 27617288; PubMed
Central PMCID: PMC5010371.


28: Wong EM, Joo JE, McLean CA, Baglietto L, English DR, Severi G, Wu HC, Terry
MB, Hopper JL, Milne RL, Giles GG, Southey MC. Analysis of the breast cancer
methylome using formalin-fixed paraffin-embedded tumour. Breast Cancer Res Treat.
2016 Nov;160(1):173-180. Epub 2016 Sep 7. PubMed PMID: 27604360.


29: Yee SS, Lieberman DB, Blanchard T, Rader J, Zhao J, Troxel AB, DeSloover D,
Fox AJ, Daber RD, Kakrecha B, Sukhadia S, Belka GK, DeMichele AM, Chodosh LA,
Morrissette JJ, Carpenter EL. A novel approach for next-generation sequencing of 
circulating tumor cells. Mol Genet Genomic Med. 2016 Feb 28;4(4):395-406. doi:
10.1002/mgg3.210. eCollection 2016 Jul. PubMed PMID: 27468416; PubMed Central
PMCID: PMC4947859.


30: Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL,
Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer
C, Caldes T, Caligo MA, Campbell I, Chan SB, Claes KB, Cohn DE, Cook J, Daly MB, 
Damiola F, Davidson R, Pauw Ad, Delnatte C, Diez O, Domchek SM, Dumont M, Durda
K, Dworniczak B, Easton DF, Eccles D, Edwinsdotter Ardnor C, Eeles R, Ejlertsen
B, Ellis S, Evans DG, Feliubadalo L, Fostira F, Foulkes WD, Friedman E, Frost D, 
Gaddam P, Ganz PA, Garber J, Garcia-Barberan V, Gauthier-Villars M, Gehrig A,
Gerdes AM, Giraud S, Godwin AK, Goldgar DE, Hake CR, Hansen TV, Healey S, Hodgson
S, Hogervorst FB, Houdayer C, Hulick PJ, Imyanitov EN, Isaacs C, Izatt L,
Izquierdo A, Jacobs L, Jakubowska A, Janavicius R, Jaworska-Bieniek K, Jensen UB,
John EM, Vijai J, Karlan BY, Kast K, Investigators K, Khan S, Kwong A, Laitman Y,
Lester J, Lesueur F, Liljegren A, Lubinski J, Mai PL, Manoukian S, Mazoyer S,
Meindl A, Mensenkamp AR, Montagna M, Nathanson KL, Neuhausen SL, Nevanlinna H,
Niederacher D, Olah E, Olopade OI, Ong KR, Osorio A, Park SK, Paulsson-Karlsson
Y, Pedersen IS, Peissel B, Peterlongo P, Pfeiler G, Phelan CM, Piedmonte M, Poppe
B, Pujana MA, Radice P, Rennert G, Rodriguez GC, Rookus MA, Ross EA, Schmutzler
RK, Simard J, Singer CF, Slavin TP, Soucy P, Southey M, Steinemann D,
Stoppa-Lyonnet D, Sukiennicki G, Sutter C, Szabo CI, Tea MK, Teixeira MR, Teo SH,
Terry MB, Thomassen M, Tibiletti MG, Tihomirova L, Tognazzo S, van Rensburg EJ,
Varesco L, Varon-Mateeva R, Vratimos A, Weitzel JN, McGuffog L, Kirk J, Toland
AE, Hamann U, Lindor N, Ramus SJ, Greene MH, Couch FJ, Offit K, Pharoah PD,
Chenevix-Trench G, Antoniou AC. Fine-Scale Mapping at 9p22.2 Identifies Candidate
Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation
Carriers. PLoS One. 2016 Jul 27;11(7):e0158801. doi:
10.1371/journal.pone.0158801. eCollection 2016. PubMed PMID: 27463617; PubMed
Central PMCID: PMC4963094.


31: Meunier A, Hernández-Castro JA, Turner K, Li K, Veres T, Juncker D.
Combination of Mechanical and Molecular Filtration for Enhanced Enrichment of
Circulating Tumor Cells. Anal Chem. 2016 Sep 6;88(17):8510-7. doi:
10.1021/acs.analchem.6b01324. Epub 2016 Aug 9. PubMed PMID: 27442305.


32: Han MR, Long J, Choi JY, Low SK, Kweon SS, Zheng Y, Cai Q, Shi J, Guo X,
Matsuo K, Iwasaki M, Shen CY, Kim MK, Wen W, Li B, Takahashi A, Shin MH, Xiang
YB, Ito H, Kasuga Y, Noh DY, Matsuda K, Park MH, Gao YT, Iwata H, Tsugane S, Park
SK, Kubo M, Shu XO, Kang D, Zheng W. Genome-wide association study in East Asians
identifies two novel breast cancer susceptibility loci. Hum Mol Genet. 2016 Aug
1;25(15):3361-3371. doi: 10.1093/hmg/ddw164. Epub 2016 Jun 27. PubMed PMID:
27354352; PubMed Central PMCID: PMC5179918.


33: Pan Z, Fu Z, Song Q, Cao W, Cheng W, Xu X. Genetic polymorphisms and
haplotype of hormone-related genes are associated with the risk of breast cancer 
in Chinese women. Genet Mol Res. 2016 May 13;15(2). doi: 10.4238/gmr.15028640.
PubMed PMID: 27323034.


34: Huo Y, Su T, Cai Q, Macara IG. An In Vivo Gain-of-Function Screen Identifies 
the Williams-Beuren Syndrome Gene GTF2IRD1 as a Mammary Tumor Promoter. Cell Rep.
2016 Jun 7;15(10):2089-2096. doi: 10.1016/j.celrep.2016.05.011. Epub 2016 May 26.
PubMed PMID: 27239038; PubMed Central PMCID: PMC5412078.


35: Morganella S, Alexandrov LB, Glodzik D, Zou X, Davies H, Staaf J, Sieuwerts
AM, Brinkman AB, Martin S, Ramakrishna M, Butler A, Kim HY, Borg Å, Sotiriou C,
Futreal PA, Campbell PJ, Span PN, Van Laere S, Lakhani SR, Eyfjord JE, Thompson
AM, Stunnenberg HG, van de Vijver MJ, Martens JW, Børresen-Dale AL, Richardson
AL, Kong G, Thomas G, Sale J, Rada C, Stratton MR, Birney E, Nik-Zainal S. The
topography of mutational processes in breast cancer genomes. Nat Commun. 2016 May
2;7:11383. doi: 10.1038/ncomms11383. PubMed PMID: 27136393; PubMed Central PMCID:
PMC5001788.


36: Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X,
Martincorena I, Alexandrov LB, Martin S, Wedge DC, Van Loo P, Ju YS, Smid M,
Brinkman AB, Morganella S, Aure MR, Lingjærde OC, Langerød A, Ringnér M, Ahn SM, 
Boyault S, Brock JE, Broeks A, Butler A, Desmedt C, Dirix L, Dronov S, Fatima A, 
Foekens JA, Gerstung M, Hooijer GK, Jang SJ, Jones DR, Kim HY, King TA,
Krishnamurthy S, Lee HJ, Lee JY, Li Y, McLaren S, Menzies A, Mustonen V, O'Meara 
S, Pauporté I, Pivot X, Purdie CA, Raine K, Ramakrishnan K, Rodríguez-González
FG, Romieu G, Sieuwerts AM, Simpson PT, Shepherd R, Stebbings L, Stefansson OA,
Teague J, Tommasi S, Treilleux I, Van den Eynden GG, Vermeulen P, Vincent-Salomon
A, Yates L, Caldas C, van't Veer L, Tutt A, Knappskog S, Tan BK, Jonkers J, Borg 
Å, Ueno NT, Sotiriou C, Viari A, Futreal PA, Campbell PJ, Span PN, Van Laere S,
Lakhani SR, Eyfjord JE, Thompson AM, Birney E, Stunnenberg HG, van de Vijver MJ, 
Martens JW, Børresen-Dale AL, Richardson AL, Kong G, Thomas G, Stratton MR.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature. 2016 Jun 2;534(7605):47-54. doi: 10.1038/nature17676. Epub 2016 May 2.
PubMed PMID: 27135926; PubMed Central PMCID: PMC4910866.


37: Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S,
Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C,
Andrulis IL, Anton-Culver H, Arndt V, Arun BK, Arver B, Barile M, Barkardottir
RB, Barrowdale D, Beckmann L, Beckmann MW, Benitez J, Blank SV, Blomqvist C,
Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch H, Brenner H, Burwinkel B, 
Buys SS, Caldes T, Caligo MA, Canzian F, Carpenter J, Chang-Claude J, Chanock SJ,
Chung WK, Claes KB, Cox A, Cross SS, Cunningham JM, Czene K, Daly MB, Damiola F, 
Darabi H, de la Hoya M, Devilee P, Diez O, Ding YC, Dolcetti R, Domchek SM,
Dorfling CM, Dos-Santos-Silva I, Dumont M, Dunning AM, Eccles DM, Ehrencrona H,
Ekici AB, Eliassen H, Ellis S, Fasching PA, Figueroa J, Flesch-Janys D, Försti A,
Fostira F, Foulkes WD, Friebel T, Friedman E, Frost D, Gabrielson M, Gammon MD,
Ganz PA, Gapstur SM, Garber J, Gaudet MM, Gayther SA, Gerdes AM, Ghoussaini M,
Giles GG, Glendon G, Godwin AK, Goldberg MS, Goldgar DE, González-Neira A, Greene
MH, Gronwald J, Guénel P, Gunter M, Haeberle L, Haiman CA, Hamann U, Hansen TV,
Hart S, Healey S, Heikkinen T, Henderson BE, Herzog J, Hogervorst FB, Hollestelle
A, Hooning MJ, Hoover RN, Hopper JL, Humphreys K, Hunter DJ, Huzarski T,
Imyanitov EN, Isaacs C, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, 
Jones M, Kabisch M, Kar S, Karlan BY, Khan S, Khaw KT, Kibriya MG, Knight JA, Ko 
YD, Konstantopoulou I, Kosma VM, Kristensen V, Kwong A, Laitman Y, Lambrechts D, 
Lazaro C, Lee E, Le Marchand L, Lester J, Lindblom A, Lindor N, Lindstrom S, Liu 
J, Long J, Lubinski J, Mai PL, Makalic E, Malone KE, Mannermaa A, Manoukian S,
Margolin S, Marme F, Martens JW, McGuffog L, Meindl A, Miller A, Milne RL, Miron 
P, Montagna M, Mazoyer S, Mulligan AM, Muranen TA, Nathanson KL, Neuhausen SL,
Nevanlinna H, Nordestgaard BG, Nussbaum RL, Offit K, Olah E, Olopade OI, Olson
JE, Osorio A, Park SK, Peeters PH, Peissel B, Peterlongo P, Peto J, Phelan CM,
Pilarski R, Poppe B, Pylkäs K, Radice P, Rahman N, Rantala J, Rappaport C,
Rennert G, Richardson A, Robson M, Romieu I, Rudolph A, Rutgers EJ, Sanchez MJ,
Santella RM, Sawyer EJ, Schmidt DF, Schmidt MK, Schmutzler RK, Schumacher F,
Scott R, Senter L, Sharma P, Simard J, Singer CF, Sinilnikova OM, Soucy P,
Southey M, Steinemann D, Stenmark-Askmalm M, Stoppa-Lyonnet D, Swerdlow A, Szabo 
CI, Tamimi R, Tapper W, Teixeira MR, Teo SH, Terry MB, Thomassen M, Thompson D,
Tihomirova L, Toland AE, Tollenaar RA, Tomlinson I, Truong T, Tsimiklis H, Teulé 
A, Tumino R, Tung N, Turnbull C, Ursin G, van Deurzen CH, van Rensburg EJ,
Varon-Mateeva R, Wang Z, Wang-Gohrke S, Weiderpass E, Weitzel JN, Whittemore A,
Wildiers H, Winqvist R, Yang XR, Yannoukakos D, Yao S, Zamora MP, Zheng W, Hall
P, Kraft P, Vachon C, Slager S, Chenevix-Trench G, Pharoah PD, Monteiro AA,
García-Closas M, Easton DF, Antoniou AC. Identification of four novel
susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun.
2016 Apr 27;7:11375. doi: 10.1038/ncomms11375. PubMed PMID: 27117709; PubMed
Central PMCID: PMC4853421.


38: Maleva Kostovska I, Wang J, Bogdanova N, Schürmann P, Bhuju S, Geffers R,
Dürst M, Liebrich C, Klapdor R, Christiansen H, Park-Simon TW, Hillemanns P,
Plaseska-Karanfilska D, Dörk T. Rare ATAD5 missense variants in breast and
ovarian cancer patients. Cancer Lett. 2016 Jun 28;376(1):173-7. doi:
10.1016/j.canlet.2016.03.048. Epub 2016 Apr 1. PubMed PMID: 27045477.


39: Desmedt C, Yates L, Kulka J. Catalog of genetic progression of human cancers:
breast cancer. Cancer Metastasis Rev. 2016 Mar;35(1):49-62. doi:
10.1007/s10555-016-9609-1. Review. PubMed PMID: 26951551.


40: Liu H, Li J, Koirala P, Ding X, Chen B, Wang Y, Wang Z, Wang C, Zhang X, Mo
YY. Long non-coding RNAs as prognostic markers in human breast cancer.
Oncotarget. 2016 Apr 12;7(15):20584-96. doi: 10.18632/oncotarget.7828. PubMed
PMID: 26942882; PubMed Central PMCID: PMC4991477.


41: Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA,
Burnside ES. Developing a utility decision framework to evaluate predictive
models in breast cancer risk estimation. J Med Imaging (Bellingham). 2015
Oct;2(4):041005. doi: 10.1117/1.JMI.2.4.041005. Epub 2015 Aug 17. PubMed PMID:
26835489; PubMed Central PMCID: PMC4718446.


42: Johnson DB, Estrada MV, Salgado R, Sanchez V, Doxie DB, Opalenik SR, Vilgelm 
AE, Feld E, Johnson AS, Greenplate AR, Sanders ME, Lovly CM, Frederick DT, Kelley
MC, Richmond A, Irish JM, Shyr Y, Sullivan RJ, Puzanov I, Sosman JA, Balko JM.
Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and 
predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016 Jan 29;7:10582.
doi: 10.1038/ncomms10582. PubMed PMID: 26822383; PubMed Central PMCID:
PMC4740184.


43: Cajanus K, Holmström EJ, Wessman M, Anttila V, Kaunisto MA, Kalso E. Effect
of endocannabinoid degradation on pain: role of FAAH polymorphisms in
experimental and postoperative pain in women treated for breast cancer. Pain.
2016 Feb;157(2):361-9. doi: 10.1097/j.pain.0000000000000398. PubMed PMID:
26808012.


44: Ruiz-Narváez EA, Haddad SA, Lunetta KL, Yao S, Bensen JT, Sucheston-Campbell 
LE, Hong CC, Haiman CA, Olshan AF, Ambrosone CB, Palmer JR. Gene-based analysis
of the fibroblast growth factor receptor signaling pathway in relation to breast 
cancer in African American women: the AMBER consortium. Breast Cancer Res Treat. 
2016 Jan;155(2):355-63. doi: 10.1007/s10549-015-3672-0. Epub 2016 Jan 7. PubMed
PMID: 26743380; PubMed Central PMCID: PMC4890604.


45: Ikeda Y, Kiyotani K, Yew PY, Kato T, Tamura K, Yap KL, Nielsen SM, Mester JL,
Eng C, Nakamura Y, Grogan RH. Germline PARP4 mutations in patients with primary
thyroid and breast cancers. Endocr Relat Cancer. 2016 Mar;23(3):171-9. doi:
10.1530/ERC-15-0359. Epub 2015 Dec 23. PubMed PMID: 26699384; PubMed Central
PMCID: PMC5152685.


46: Arkova OV, Ponomarenko MP, Rasskazov DA, Drachkova IA, Arshinova TV,
Ponomarenko PM, Savinkova LK, Kolchanov NA. Obesity-related known and candidate
SNP markers can significantly change affinity of TATA-binding protein for human
gene promoters. BMC Genomics. 2015;16 Suppl 13:S5. doi:
10.1186/1471-2164-16-S13-S5. Epub 2015 Dec 16. PubMed PMID: 26694100; PubMed
Central PMCID: PMC4686794.


47: Nikitina D, Chen Z, Vallis K, Poll A, Ainsworth P, Narod SA, Kotsopoulos J.
Relationship between Caffeine and Levels of DNA Repair and Oxidative Stress in
Women with and without a BRCA1 Mutation. J Nutrigenet Nutrigenomics.
2015;8(4-6):174-84. doi: 10.1159/000439110. Epub 2015 Dec 16. PubMed PMID:
26670362.


48: Shabnaz S, Ahmed MU, Islam MS, Islam MR, Al-Mamun MM, Islam MS, Hasnat A.
Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in
the Bangladeshi women. Tumour Biol. 2016 Jun;37(6):7229-37. doi:
10.1007/s13277-015-4612-7. Epub 2015 Dec 14. PubMed PMID: 26666818.


49: Gao Y, Jones A, Fasching PA, Ruebner M, Beckmann MW, Widschwendter M,
Teschendorff AE. The integrative epigenomic-transcriptomic landscape of ER
positive breast cancer. Clin Epigenetics. 2015 Dec 9;7:126. doi:
10.1186/s13148-015-0159-0. eCollection 2015. Erratum in: Clin Epigenetics.
2016;8:63. PubMed PMID: 26664652; PubMed Central PMCID: PMC4673726.


50: Brightwell RM, Grzankowski KS, Kaur J, Poblete S, Miller A, Lele SB,
Sucheston-Campbell L, Moysich K, Odunsi KO. Higher than expected frequencies of
non-ovarian cancers within a large familial ovarian cancer registry. Am J Clin
Exp Obstet Gynecol. 2015;2(1):39-44. Epub 2015 Feb 15. PubMed PMID: 26605374;
PubMed Central PMCID: PMC4655182.


51: Gee HE, Buffa FM, Harris AL, Toohey JM, Carroll SL, Cooper CL, Beith J,
McNeil C, Carmalt H, Mak C, Warrier S, Holliday A, Selinger C, Beckers R, Kennedy
C, Graham P, Swarbrick A, Millar EK, O'Toole SA, Molloy T. MicroRNA-Related DNA
Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation
Therapy for Early Breast Cancer. Int J Radiat Oncol Biol Phys. 2015 Dec
1;93(5):1104-14. doi: 10.1016/j.ijrobp.2015.08.046. Epub 2015 Sep 3. PubMed PMID:
26581147.


52: Dorling L, Barnett GC, Michailidou K, Coles CE, Burnet NG, Yarnold J, Elliott
RM, Dunning AM, Pharoah PD, West CM. Patients with a High Polygenic Risk of
Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity. Clin Cancer
Res. 2016 Mar 15;22(6):1413-20. doi: 10.1158/1078-0432.CCR-15-1080. Epub 2015 Oct
28. PubMed PMID: 26510858; PubMed Central PMCID: PMC4751620.


53: Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N,
Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt
C, Piccart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V. Principles
Governing A-to-I RNA Editing in the Breast Cancer Transcriptome. Cell Rep. 2015
Oct 13;13(2):277-89. doi: 10.1016/j.celrep.2015.09.032. Epub 2015 Oct 1. PubMed
PMID: 26440892; PubMed Central PMCID: PMC5326813.


54: Jonsson P, Coarfa C, Mesmar F, Raz T, Rajapakshe K, Thompson JF, Gunaratne
PH, Williams C. Single-Molecule Sequencing Reveals Estrogen-Regulated Clinically 
Relevant lncRNAs in Breast Cancer. Mol Endocrinol. 2015 Nov;29(11):1634-45. doi: 
10.1210/me.2015-1153. Epub 2015 Oct 1. PubMed PMID: 26426411; PubMed Central
PMCID: PMC4627604.


55: Kinnersley B, Labussière M, Holroyd A, Di Stefano AL, Broderick P,
Vijayakrishnan J, Mokhtari K, Delattre JY, Gousias K, Schramm J, Schoemaker MJ,
Fleming SJ, Herms S, Heilmann S, Schreiber S, Wichmann HE, Nöthen MM, Swerdlow A,
Lathrop M, Simon M, Bondy M, Sanson M, Houlston RS. Genome-wide association study
identifies multiple susceptibility loci for glioma. Nat Commun. 2015 Oct
1;6:8559. doi: 10.1038/ncomms9559. PubMed PMID: 26424050; PubMed Central PMCID:
PMC4600760.


56: Lebo PB, Quehenberger F, Kamolz LP, Lumenta DB. The Angelina effect
revisited: Exploring a media-related impact on public awareness. Cancer. 2015 Nov
15;121(22):3959-64. doi: 10.1002/cncr.29461. Epub 2015 Sep 28. PubMed PMID:
26414603.


57: Katz TA, Liao SG, Palmieri VJ, Dearth RK, Pathiraja TN, Huo Z, Shaw P, Small 
S, Davidson NE, Peters DG, Tseng GC, Oesterreich S, Lee AV. Targeted DNA
Methylation Screen in the Mouse Mammary Genome Reveals a Parity-Induced
Hypermethylation of Igf1r That Persists Long after Parturition. Cancer Prev Res
(Phila). 2015 Oct;8(10):1000-9. doi: 10.1158/1940-6207.CAPR-15-0178. Epub 2015
Aug 19. PubMed PMID: 26290394; PubMed Central PMCID: PMC4677681.


58: Hong E, Best A, Gautrey H, Chin J, Razdan A, Curk T, Elliott DJ, Tyson-Capper
AJ. Unravelling the RNA-Binding Properties of SAFB Proteins in Breast Cancer
Cells. Biomed Res Int. 2015;2015:395816. doi: 10.1155/2015/395816. Epub 2015 Jul 
26. PubMed PMID: 26273616; PubMed Central PMCID: PMC4529905.


59: Van Keymeulen A, Lee MY, Ousset M, Brohée S, Rorive S, Giraddi RR, Wuidart A,
Bouvencourt G, Dubois C, Salmon I, Sotiriou C, Phillips WA, Blanpain C.
Reactivation of multipotency by oncogenic PIK3CA induces breast tumour
heterogeneity. Nature. 2015 Sep 3;525(7567):119-23. doi: 10.1038/nature14665.
Epub 2015 Aug 12. PubMed PMID: 26266985.


60: Lincoln SE, Kobayashi Y, Anderson MJ, Yang S, Desmond AJ, Mills MA, Nilsen
GB, Jacobs KB, Monzon FA, Kurian AW, Ford JM, Ellisen LW. A Systematic Comparison
of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian
Cancer Genes in More Than 1000 Patients. J Mol Diagn. 2015 Sep;17(5):533-44. doi:
10.1016/j.jmoldx.2015.04.009. Epub 2015 Jul 22. PubMed PMID: 26207792.


61: Noh JM, Kim J, Cho DY, Choi DH, Park W, Huh SJ. Exome sequencing in a breast 
cancer family without BRCA mutation. Radiat Oncol J. 2015 Jun;33(2):149-54. doi: 
10.3857/roj.2015.33.2.149. Epub 2015 Jun 30. PubMed PMID: 26157685; PubMed
Central PMCID: PMC4493427.


62: Tarabichi M, Saiselet M, Trésallet C, Hoang C, Larsimont D, Andry G, Maenhaut
C, Detours V. Revisiting the transcriptional analysis of primary tumours and
associated nodal metastases with enhanced biological and statistical controls:
application to thyroid cancer. Br J Cancer. 2015 May 12;112(10):1665-74. doi:
10.1038/bjc.2014.665. PubMed PMID: 25965298; PubMed Central PMCID: PMC4430711.


63: Livshits A, Git A, Fuks G, Caldas C, Domany E. Pathway-based personalized
analysis of breast cancer expression data. Mol Oncol. 2015 Aug;9(7):1471-83. doi:
10.1016/j.molonc.2015.04.006. Epub 2015 Apr 29. PubMed PMID: 25963740; PubMed
Central PMCID: PMC5528809.


64: Ju YS, Tubio JM, Mifsud W, Fu B, Davies HR, Ramakrishna M, Li Y, Yates L,
Gundem G, Tarpey PS, Behjati S, Papaemmanuil E, Martin S, Fullam A, Gerstung M;
ICGC Prostate Cancer Working Group; ICGC Bone Cancer Working Group; ICGC Breast
Cancer Working Group, Nangalia J, Green AR, Caldas C, Borg Å, Tutt A, Lee MT,
van't Veer LJ, Tan BK, Aparicio S, Span PN, Martens JW, Knappskog S,
Vincent-Salomon A, Børresen-Dale AL, Eyfjörd JE, Myklebost O, Flanagan AM, Foster
C, Neal DE, Cooper C, Eeles R, Bova SG, Lakhani SR, Desmedt C, Thomas G,
Richardson AL, Purdie CA, Thompson AM, McDermott U, Yang F, Nik-Zainal S,
Campbell PJ, Stratton MR. Frequent somatic transfer of mitochondrial DNA into the
nuclear genome of human cancer cells. Genome Res. 2015 Jun;25(6):814-24. doi:
10.1101/gr.190470.115. Epub 2015 May 11. Erratum in: Genome Res. 2016
May;26(5):717.2. PubMed PMID: 25963125; PubMed Central PMCID: PMC4448678.


65: Leyland-Jones B, Gray KP, Abramovitz M, Bouzyk M, Young B, Long B, Kammler R,
Dell'Orto P, Biasi MO, Thürlimann B, Lyng MB, Ditzel HJ, Harvey VJ, Neven P,
Treilleux I, Rasmussen BB, Maibach R, Price KN, Coates AS, Goldhirsch A, Pagani
O, Viale G, Rae JM, Regan MM. CYP19A1 polymorphisms and clinical outcomes in
postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98
trial. Breast Cancer Res Treat. 2015 Jun;151(2):373-84. doi:
10.1007/s10549-015-3378-3. Epub 2015 May 3. PubMed PMID: 25935582; PubMed Central
PMCID: PMC4763278.


66: Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK,
Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, Shah M,
Czene K, Darabi H, Eriksson M, Lambrechts D, Weltens C, Leunen K, Bojesen SE,
Nordestgaard BG, Nielsen SF, Flyger H, Chang-Claude J, Rudolph A, Seibold P,
Flesch-Janys D, Blomqvist C, Aittomäki K, Fagerholm R, Muranen TA, Couch FJ,
Olson JE, Vachon C, Andrulis IL, Knight JA, Glendon G, Mulligan AM, Broeks A,
Hogervorst FB, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Hopper JL,
Tsimiklis H, Apicella C, Southey MC, Cox A, Cross SS, Reed MW, Giles GG, Milne
RL, McLean C, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Hooning MJ,
Hollestelle A, Martens JW, van den Ouweland AM, Marme F, Schneeweiss A, Yang R,
Burwinkel B, Figueroa J, Chanock SJ, Lissowska J, Sawyer EJ, Tomlinson I, Kerin
MJ, Miller N, Brenner H, Dieffenbach AK, Arndt V, Holleczek B, Mannermaa A,
Kataja V, Kosma VM, Hartikainen JM, Li J, Brand JS, Humphreys K, Devilee P,
Tollenaar RA, Seynaeve C, Radice P, Peterlongo P, Bonanni B, Mariani P, Fasching 
PA, Beckmann MW, Hein A, Ekici AB, Chenevix-Trench G, Balleine R; kConFab
Investigators, Phillips KA, Benitez J, Zamora MP, Arias Perez JI, Menéndez P,
Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Hamann U, Kabisch M, Ulmer
HU, Rüdiger T, Margolin S, Kristensen V, Nord S, Evans DG, Abraham JE, Earl HM,
Hiller L, Dunn JA, Bowden S, Berg C, Campa D, Diver WR, Gapstur SM, Gaudet MM,
Hankinson SE, Hoover RN, Hüsing A, Kaaks R, Machiela MJ, Willett W, Barrdahl M,
Canzian F, Chin SF, Caldas C, Hunter DJ, Lindstrom S, García-Closas M, Hall P,
Easton DF, Eccles DM, Rahman N, Nevanlinna H, Pharoah PD. Identification of novel
genetic markers of breast cancer survival. J Natl Cancer Inst. 2015 Apr
18;107(5). pii: djv081. doi: 10.1093/jnci/djv081. Print 2015 May. PubMed PMID:
25890600; PubMed Central PMCID: PMC4555642.


67: Fonville NC, Vaksman Z, McIver LJ, Garner HR. Population analysis of
microsatellite genotypes reveals a signature associated with ovarian cancer.
Oncotarget. 2015 May 10;6(13):11407-20. PubMed PMID: 25779658; PubMed Central
PMCID: PMC4484465.


68: Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ,
Maranian MJ, Bolla MK, Wang Q, Shah M, Perkins BJ, Czene K, Eriksson M, Darabi H,
Brand JS, Bojesen SE, Nordestgaard BG, Flyger H, Nielsen SF, Rahman N, Turnbull
C; BOCS, Fletcher O, Peto J, Gibson L, dos-Santos-Silva I, Chang-Claude J,
Flesch-Janys D, Rudolph A, Eilber U, Behrens S, Nevanlinna H, Muranen TA,
Aittomäki K, Blomqvist C, Khan S, Aaltonen K, Ahsan H, Kibriya MG, Whittemore AS,
John EM, Malone KE, Gammon MD, Santella RM, Ursin G, Makalic E, Schmidt DF, Casey
G, Hunter DJ, Gapstur SM, Gaudet MM, Diver WR, Haiman CA, Schumacher F, Henderson
BE, Le Marchand L, Berg CD, Chanock SJ, Figueroa J, Hoover RN, Lambrechts D,
Neven P, Wildiers H, van Limbergen E, Schmidt MK, Broeks A, Verhoef S,
Cornelissen S, Couch FJ, Olson JE, Hallberg E, Vachon C, Waisfisz Q,
Meijers-Heijboer H, Adank MA, van der Luijt RB, Li J, Liu J, Humphreys K, Kang D,
Choi JY, Park SK, Yoo KY, Matsuo K, Ito H, Iwata H, Tajima K, Guénel P, Truong T,
Mulot C, Sanchez M, Burwinkel B, Marme F, Surowy H, Sohn C, Wu AH, Tseng CC, Van 
Den Berg D, Stram DO, González-Neira A, Benitez J, Zamora MP, Perez JI, Shu XO,
Lu W, Gao YT, Cai H, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G,
Mulligan AM, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N; kConFab Investigators;
AOCS Group, Lindblom A, Margolin S, Teo SH, Yip CH, Taib NA, Tan GH, Hooning MJ, 
Hollestelle A, Martens JW, Collée JM, Blot W, Signorello LB, Cai Q, Hopper JL,
Southey MC, Tsimiklis H, Apicella C, Shen CY, Hsiung CN, Wu PE, Hou MF,
Kristensen VN, Nord S, Alnaes GI; NBCS, Giles GG, Milne RL, McLean C, Canzian F, 
Trichopoulos D, Peeters P, Lund E, Sund M, Khaw KT, Gunter MJ, Palli D, Mortensen
LM, Dossus L, Huerta JM, Meindl A, Schmutzler RK, Sutter C, Yang R, Muir K,
Lophatananon A, Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Chia KS,
Chan CW, Fasching PA, Hein A, Beckmann MW, Haeberle L, Brenner H, Dieffenbach AK,
Arndt V, Stegmaier C, Ashworth A, Orr N, Schoemaker MJ, Swerdlow AJ, Brinton L,
Garcia-Closas M, Zheng W, Halverson SL, Shrubsole M, Long J, Goldberg MS,
Labrèche F, Dumont M, Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H,
Hamann U, Brüning T; GENICA Network, Radice P, Peterlongo P, Manoukian S, Bernard
L, Bogdanova NV, Dörk T, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Devilee
P, Tollenaar RA, Seynaeve C, Van Asperen CJ, Jakubowska A, Lubinski J, Jaworska
K, Huzarski T, Sangrajrang S, Gaborieau V, Brennan P, McKay J, Slager S, Toland
AE, Ambrosone CB, Yannoukakos D, Kabisch M, Torres D, Neuhausen SL, Anton-Culver 
H, Luccarini C, Baynes C, Ahmed S, Healey CS, Tessier DC, Vincent D, Bacot F,
Pita G, Alonso MR, Álvarez N, Herrero D, Simard J, Pharoah PP, Kraft P, Dunning
AM, Chenevix-Trench G, Hall P, Easton DF. Genome-wide association analysis of
more than 120,000 individuals identifies 15 new susceptibility loci for breast
cancer. Nat Genet. 2015 Apr;47(4):373-80. doi: 10.1038/ng.3242. Epub 2015 Mar 9. 
PubMed PMID: 25751625; PubMed Central PMCID: PMC4549775.


69: Fachal L, Dunning AM. From candidate gene studies to GWAS and post-GWAS
analyses in breast cancer. Curr Opin Genet Dev. 2015 Feb;30:32-41. doi:
10.1016/j.gde.2015.01.004. Epub 2015 Feb 27. Review. PubMed PMID: 25727315.


70: Good BM, Loguercio S, Griffith OL, Nanis M, Wu C, Su AI. The cure: design and
evaluation of a crowdsourcing game for gene selection for breast cancer survival 
prediction. JMIR Serious Games. 2014 Jul 29;2(2):e7. doi: 10.2196/games.3350.
PubMed PMID: 25654473; PubMed Central PMCID: PMC4307816.


71: Sobota RS, Shriner D, Kodaman N, Goodloe R, Zheng W, Gao YT, Edwards TL, Amos
CI, Williams SM. Addressing population-specific multiple testing burdens in
genetic association studies. Ann Hum Genet. 2015 Mar;79(2):136-47. doi:
10.1111/ahg.12095. Epub 2015 Jan 22. PubMed PMID: 25644736; PubMed Central PMCID:
PMC4334751.


72: Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, Michailidou K, Bolla MK,
Wang Q, Dennis J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, 
Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D, Neven P, Peeters S, Weltens 
C, Couch FJ, Olson JE, Wang X, Purrington K, Chang-Claude J, Rudolph A, Seibold
P, Flesch-Janys D, Peto J, dos-Santos-Silva I, Johnson N, Fletcher O, Nevanlinna 
H, Muranen TA, Aittomäki K, Blomqvist C, Schmidt MK, Broeks A, Cornelissen S,
Hogervorst FB, Li J, Brand JS, Humphreys K, Guénel P, Truong T, Menegaux F,
Sanchez M, Burwinkel B, Marmé F, Yang R, Bugert P, González-Neira A, Benitez J,
Pilar Zamora M, Arias Perez JI, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA,
Glendon G, Tchatchou S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N; kConFab
Investigators; Australian Ovarian Cancer Study Group, Haiman CA, Schumacher F,
Henderson BE, Le Marchand L, Lindblom A, Margolin S, Hooning MJ, Hollestelle A,
Kriege M, Koppert LB, Hopper JL, Southey MC, Tsimiklis H, Apicella C, Slettedahl 
S, Toland AE, Vachon C, Yannoukakos D, Giles GG, Milne RL, McLean C, Fasching PA,
Ruebner M, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt V, Stegmaier
C, Ashworth A, Orr N, Schoemaker MJ, Swerdlow A, García-Closas M, Figueroa J,
Chanock SJ, Lissowska J, Goldberg MS, Labrèche F, Dumont M, Winqvist R, Pylkäs K,
Jukkola-Vuorinen A, Grip M, Brauch H, Brüning T, Ko YD; GENICA Network, Radice P,
Peterlongo P, Scuvera G, Fortuzzi S, Bogdanova N, Dörk T, Mannermaa A, Kataja V, 
Kosma VM, Hartikainen JM, Devilee P, Tollenaar RA, Seynaeve C, Van Asperen CJ,
Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Zheng W, Shrubsole MJ, Cai
Q, Torres D, Anton-Culver H, Kristensen V, Bacot F, Tessier DC, Vincent D,
Luccarini C, Baynes C, Ahmed S, Maranian M, Simard J, Chenevix-Trench G, Hall P, 
Pharoah PD, Dunning AM, Easton DF, Hamann U. Inherited variants in the inner
centromere protein (INCENP) gene of the chromosomal passenger complex contribute 
to the susceptibility of ER-negative breast cancer. Carcinogenesis. 2015
Feb;36(2):256-71. doi: 10.1093/carcin/bgu326. Epub 2015 Jan 13. PubMed PMID:
25586992; PubMed Central PMCID: PMC4335262.


73: Pižem J, Velikonja M, Matjašič A, Jerše M, Glavač D. Pseudoangiomatous
stromal hyperplasia with multinucleated stromal giant cells is neither
exceptional in gynecomastia nor characteristic of neurofibromatosis type 1.
Virchows Arch. 2015 Apr;466(4):465-72. doi: 10.1007/s00428-014-1715-2. Epub 2015 
Jan 14. PubMed PMID: 25586494.


74: Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, 
McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q,
Coetzee S, Hazelett D, Miron A, Southey M, Terry MB, Goldgar DE, Buys SS,
Janavicius R, Dorfling CM, van Rensburg EJ, Neuhausen SL, Ding YC, Hansen TV,
Jønson L, Gerdes AM, Ejlertsen B, Barrowdale D, Dennis J, Benitez J, Osorio A,
Garcia MJ, Komenaka I, Weitzel JN, Ganschow P, Peterlongo P, Bernard L, Viel A,
Bonanni B, Peissel B, Manoukian S, Radice P, Papi L, Ottini L, Fostira F,
Konstantopoulou I, Garber J, Frost D, Perkins J, Platte R, Ellis S; EMBRACE,
Godwin AK, Schmutzler RK, Meindl A, Engel C, Sutter C, Sinilnikova OM; GEMO Study
Collaborators, Damiola F, Mazoyer S, Stoppa-Lyonnet D, Claes K, De Leeneer K,
Kirk J, Rodriguez GC, Piedmonte M, O'Malley DM, de la Hoya M, Caldes T, Aittomäki
K, Nevanlinna H, Collée JM, Rookus MA, Oosterwijk JC; Breast Cancer Family
Registry, Tihomirova L, Tung N, Hamann U, Isaccs C, Tischkowitz M, Imyanitov EN, 
Caligo MA, Campbell IG, Hogervorst FB; HEBON, Olah E, Diez O, Blanco I, Brunet J,
Lazaro C, Pujana MA, Jakubowska A, Gronwald J, Lubinski J, Sukiennicki G,
Barkardottir RB, Plante M, Simard J, Soucy P, Montagna M, Tognazzo S, Teixeira
MR; KConFab Investigators, Pankratz VS, Wang X, Lindor N, Szabo CI, Kauff N,
Vijai J, Aghajanian CA, Pfeiler G, Berger A, Singer CF, Tea MK, Phelan CM, Greene
MH, Mai PL, Rennert G, Mulligan AM, Tchatchou S, Andrulis IL, Glendon G, Toland
AE, Jensen UB, Kruse TA, Thomassen M, Bojesen A, Zidan J, Friedman E, Laitman Y, 
Soller M, Liljegren A, Arver B, Einbeigi Z, Stenmark-Askmalm M, Olopade OI,
Nussbaum RL, Rebbeck TR, Nathanson KL, Domchek SM, Lu KH, Karlan BY, Walsh C,
Lester J; Australian Cancer Study (Ovarian Cancer Investigators); Australian
Ovarian Cancer Study Group, Hein A, Ekici AB, Beckmann MW, Fasching PA,
Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Dicks E, Doherty JA, 
Wicklund KG, Rossing MA, Rudolph A, Chang-Claude J, Wang-Gohrke S, Eilber U,
Moysich KB, Odunsi K, Sucheston L, Lele S, Wilkens LR, Goodman MT, Thompson PJ,
Shvetsov YB, Runnebaum IB, Dürst M, Hillemanns P, Dörk T, Antonenkova N,
Bogdanova N, Leminen A, Pelttari LM, Butzow R, Modugno F, Kelley JL, Edwards RP, 
Ness RB, du Bois A, Heitz F, Schwaab I, Harter P, Matsuo K, Hosono S, Orsulic S, 
Jensen A, Kjaer SK, Hogdall E, Hasmad HN, Azmi MA, Teo SH, Woo YL, Fridley BL,
Goode EL, Cunningham JM, Vierkant RA, Bruinsma F, Giles GG, Liang D, Hildebrandt 
MA, Wu X, Levine DA, Bisogna M, Berchuck A, Iversen ES, Schildkraut JM, Concannon
P, Weber RP, Cramer DW, Terry KL, Poole EM, Tworoger SS, Bandera EV, Orlow I,
Olson SH, Krakstad C, Salvesen HB, Tangen IL, Bjorge L, van Altena AM, Aben KK,
Kiemeney LA, Massuger LF, Kellar M, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, 
Cybulski C, Yang H, Lissowska J, Brinton LA, Wentzensen N, Hogdall C, Lundvall L,
Nedergaard L, Baker H, Song H, Eccles D, McNeish I, Paul J, Carty K, Siddiqui N, 
Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Ji BT, Zheng W, Shu 
XO, Gao YT, Rosen B, Risch HA, McLaughlin JR, Narod SA, Monteiro AN, Chen A, Lin 
HY, Permuth-Wey J, Sellers TA, Tsai YY, Chen Z, Ziogas A, Anton-Culver H,
Gentry-Maharaj A, Menon U, Harrington P, Lee AW, Wu AH, Pearce CL, Coetzee G,
Pike MC, Dansonka-Mieszkowska A, Timorek A, Rzepecka IK, Kupryjanczyk J, Freedman
M, Noushmehr H, Easton DF, Offit K, Couch FJ, Gayther S, Pharoah PP, Antoniou AC,
Chenevix-Trench G; Consortium of Investigators of Modifiers of BRCA1 and BRCA2.
Identification of six new susceptibility loci for invasive epithelial ovarian
cancer. Nat Genet. 2015 Feb;47(2):164-71. doi: 10.1038/ng.3185. Epub 2015 Jan 12.
PubMed PMID: 25581431; PubMed Central PMCID: PMC4445140.


75: Rafiq S, Khan S, Tapper W, Collins A, Upstill-Goddard R, Gerty S, Blomqvist
C, Aittomäki K, Couch FJ, Liu J, Nevanlinna H, Eccles D. A genome wide
meta-analysis study for identification of common variation associated with breast
cancer prognosis. PLoS One. 2014 Dec 19;9(12):e101488. doi:
10.1371/journal.pone.0101488. eCollection 2014. PubMed PMID: 25526632; PubMed
Central PMCID: PMC4272267.


76: Gillet-Markowska A, Richard H, Fischer G, Lafontaine I. Ulysses: accurate
detection of low-frequency structural variations in large insert-size sequencing 
libraries. Bioinformatics. 2015 Mar 15;31(6):801-8. doi:
10.1093/bioinformatics/btu730. Epub 2014 Nov 7. PubMed PMID: 25380961.


77: Tsukasaki K, Tobinai K. Human T-cell lymphotropic virus type I-associated
adult T-cell leukemia-lymphoma: new directions in clinical research. Clin Cancer 
Res. 2014 Oct 15;20(20):5217-25. doi: 10.1158/1078-0432.CCR-14-0572. Review.
PubMed PMID: 25320371.


78: Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, 
Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q,
Dicks E, Guo Q, Schmidt MK, Shah M, Luben R, Brown J, Czene K, Darabi H, Eriksson
M, Klevebring D, Bojesen SE, Nordestgaard BG, Nielsen SF, Flyger H, Lambrechts D,
Thienpont B, Neven P, Wildiers H, Broeks A, Van't Veer LJ, Th Rutgers EJ, Couch
FJ, Olson JE, Hallberg E, Vachon C, Chang-Claude J, Rudolph A, Seibold P,
Flesch-Janys D, Peto J, Dos-Santos-Silva I, Gibson L, Nevanlinna H, Muranen TA,
Aittomäki K, Blomqvist C, Hall P, Li J, Liu J, Humphreys K, Kang D, Choi JY, Park
SK, Noh DY, Matsuo K, Ito H, Iwata H, Yatabe Y, Guénel P, Truong T, Menegaux F,
Sanchez M, Burwinkel B, Marme F, Schneeweiss A, Sohn C, Wu AH, Tseng CC, Van Den 
Berg D, Stram DO, Benitez J, Zamora MP, Perez JI, Menéndez P, Shu XO, Lu W, Gao
YT, Cai Q, Cox A, Cross SS, Reed MW, Andrulis IL, Knight JA, Glendon G, Tchatchou
S, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Haiman CA, Henderson BE,
Schumacher F, Le Marchand L, Lindblom A, Margolin S, Teo SH, Yip CH, Lee DS, Wong
TY, Hooning MJ, Martens JW, Collée JM, van Deurzen CH, Hopper JL, Southey MC,
Tsimiklis H, Kapuscinski MK, Shen CY, Wu PE, Yu JC, Chen ST, Alnæs GG,
Borresen-Dale AL, Giles GG, Milne RL, McLean C, Muir K, Lophatananon A,
Stewart-Brown S, Siriwanarangsan P, Hartman M, Miao H, Buhari SA, Teo YY,
Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Brenner H, Dieffenbach AK, Arndt 
V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Schoemaker MJ, García-Closas M,
Figueroa J, Chanock SJ, Lissowska J, Simard J, Goldberg MS, Labrèche F, Dumont M,
Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Brauch H, Brüning T, Koto YD, Radice P,
Peterlongo P, Bonanni B, Volorio S, Dörk T, Bogdanova NV, Helbig S, Mannermaa A, 
Kataja V, Kosma VM, Hartikainen JM, Devilee P, Tollenaar RA, Seynaeve C, Van
Asperen CJ, Jakubowska A, Lubinski J, Jaworska-Bieniek K, Durda K, Slager S,
Toland AE, Ambrosone CB, Yannoukakos D, Sangrajrang S, Gaborieau V, Brennan P,
McKay J, Hamann U, Torres D, Zheng W, Long J, Anton-Culver H, Neuhausen SL,
Luccarini C, Baynes C, Ahmed S, Maranian M, Healey CS, González-Neira A, Pita G, 
Alonso MR, Alvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, de Santiago I,
Carroll J, Caldas C, Brown MA, Lupien M, Kristensen VN, Pharoah PD,
Chenevix-Trench G, French JD, Easton DF, Dunning AM; Australian Ovarian Cancer
Management Group; Australian Ovarian Cancer Management Group. Evidence that
breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat
Commun. 2014 Sep 23;4:4999. doi: 10.1038/ncomms5999. PubMed PMID: 25248036;
PubMed Central PMCID: PMC4321900.


79: Yang Y, Swennenhuis JF, Rho HS, Le Gac S, Terstappen LW. Parallel single
cancer cell whole genome amplification using button-valve assisted mixing in
nanoliter chambers. PLoS One. 2014 Sep 18;9(9):e107958. doi:
10.1371/journal.pone.0107958. eCollection 2014. PubMed PMID: 25233459; PubMed
Central PMCID: PMC4169497.


80: Yang X, Lazar IM. XMAn: a Homo sapiens mutated-peptide database for the MS
analysis of cancerous cell states. J Proteome Res. 2014 Dec 5;13(12):5486-95.
doi: 10.1021/pr5004467. Epub 2014 Sep 29. PubMed PMID: 25211293.


81: Ali HR, Rueda OM, Chin SF, Curtis C, Dunning MJ, Aparicio SA, Caldas C.
Genome-driven integrated classification of breast cancer validated in over 7,500 
samples. Genome Biol. 2014 Aug 28;15(8):431. doi: 10.1186/s13059-014-0431-1.
PubMed PMID: 25164602; PubMed Central PMCID: PMC4166472.


82: Fleischer T, Frigessi A, Johnson KC, Edvardsen H, Touleimat N, Klajic J, Riis
ML, Haakensen VD, Wärnberg F, Naume B, Helland A, Børresen-Dale AL, Tost J,
Christensen BC, Kristensen VN. Genome-wide DNA methylation profiles in
progression to in situ and invasive carcinoma of the breast with impact on gene
transcription and prognosis. Genome Biol. 2014;15(8):435. doi:
10.1186/PREACCEPT-2333349012841587. Epub 2014 Aug 22. PubMed PMID: 25146004;
PubMed Central PMCID: PMC4165906.


83: Deplus R, Blanchon L, Rajavelu A, Boukaba A, Defrance M, Luciani J, Rothé F, 
Dedeurwaerder S, Denis H, Brinkman AB, Simmer F, Müller F, Bertin B, Berdasco M, 
Putmans P, Calonne E, Litchfield DW, de Launoit Y, Jurkowski TP, Stunnenberg HG, 
Bock C, Sotiriou C, Fraga MF, Esteller M, Jeltsch A, Fuks F. Regulation of DNA
methylation patterns by CK2-mediated phosphorylation of Dnmt3a. Cell Rep. 2014
Aug 7;8(3):743-53. doi: 10.1016/j.celrep.2014.06.048. Epub 2014 Jul 24. PubMed
PMID: 25066127.


84: Evans DG, Harkness E, Lalloo F, Howell A. Long-term prospective clinical
follow-up after BRCA1/2 presymptomatic testing: BRCA2 risks higher than in
adjusted retrospective studies. J Med Genet. 2014 Sep;51(9):573-80. doi:
10.1136/jmedgenet-2014-102336. Epub 2014 Jul 22. PubMed PMID: 25053764.


85: Tessereau C, Lesecque Y, Monnet N, Buisson M, Barjhoux L, Léoné M, Feng B,
Goldgar DE, Sinilnikova OM, Mousset S, Duret L, Mazoyer S. Estimation of the RNU2
macrosatellite mutation rate by BRCA1 mutation tracing. Nucleic Acids Res. 2014
Aug;42(14):9121-30. doi: 10.1093/nar/gku639. Epub 2014 Jul 17. PubMed PMID:
25034697; PubMed Central PMCID: PMC4132748.


86: Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collée JM, Jansen L, 
Kets CM, Keymeulen KB, Koppert LB, Meijers-Heijboer HE, Mooij TM, Tollenaar RA,
Vasen HF; HEBON, Hooning MJ, Seynaeve C. Improved overall survival after
contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a
history of unilateral breast cancer: a prospective analysis. Int J Cancer. 2015
Feb 1;136(3):668-77. doi: 10.1002/ijc.29032. Epub 2014 Jul 8. PubMed PMID:
24947112.


87: Chen X, Paranjape T, Stahlhut C, McVeigh T, Keane F, Nallur S, Miller N,
Kerin M, Deng Y, Yao X, Zhao H, Weidhaas JB, Slack FJ. Targeted resequencing of
the microRNAome and 3'UTRome reveals functional germline DNA variants with
altered prevalence in epithelial ovarian cancer. Oncogene. 2015 Apr
16;34(16):2125-37. doi: 10.1038/onc.2014.117. Epub 2014 Jun 9. PubMed PMID:
24909162; PubMed Central PMCID: PMC4326598.


88: McIver LJ, Fonville NC, Karunasena E, Garner HR. Microsatellite genotyping
reveals a signature in breast cancer exomes. Breast Cancer Res Treat. 2014
Jun;145(3):791-8. doi: 10.1007/s10549-014-2908-8. Epub 2014 May 17. PubMed PMID: 
24838940; PubMed Central PMCID: PMC4031393.


89: Chung CC, Hsing AW, Edward Yeboah, Biritwum R, Tettey Y, Adjei A, Cook MB, De
Marzo A, Netto G, Tay E, Boland JF, Yeager M, Chanock SJ. A comprehensive
resequence-analysis of 250 kb region of 8q24.21 in men of African ancestry.
Prostate. 2014 May;74(6):579-89. PubMed PMID: 24783269; PubMed Central PMCID:
PMC4199861.


90: Hergueta-Redondo M, Sarrió D, Molina-Crespo Á, Megias D, Mota A,
Rojo-Sebastian A, García-Sanz P, Morales S, Abril S, Cano A, Peinado H,
Moreno-Bueno G. Gasdermin-B promotes invasion and metastasis in breast cancer
cells. PLoS One. 2014 Mar 27;9(3):e90099. doi: 10.1371/journal.pone.0090099.
eCollection 2014. PubMed PMID: 24675552; PubMed Central PMCID: PMC3967990.


91: Ma CX, Ellis MJ. The Cancer Genome Atlas: clinical applications for breast
cancer. Oncology (Williston Park). 2013 Dec;27(12):1263-9, 1274-9. Review. PubMed
PMID: 24624545.


92: Williams CK, Cristina Stefan D, Rawlinson F, Simbiri K, Mbulaiteye SM. The
African Organisation for Research and Training in Cancer and its conferences: a
historical perspective and highlights of the Ninth International Conference,
Durban, South Africa, 21-24 November 2013. Ecancermedicalscience. 2014 Feb
3;8:396. doi: 10.3332/ecancer.2014.396. eCollection 2014. PubMed PMID: 24550997; 
PubMed Central PMCID: PMC3908628.


93: Espinosa O, Mitsopoulos K, Hakas J, Pearl F, Zvelebil M. Deriving a mutation 
index of carcinogenicity using protein structure and protein interfaces. PLoS
One. 2014 Jan 15;9(1):e84598. doi: 10.1371/journal.pone.0084598. eCollection
2014. PubMed PMID: 24454733; PubMed Central PMCID: PMC3893166.


94: Kambur O, Kaunisto MA, Tikkanen E, Leal SM, Ripatti S, Kalso EA. Effect of
catechol-o-methyltransferase-gene (COMT) variants on experimental and acute
postoperative pain in 1,000 women undergoing surgery for breast cancer.
Anesthesiology. 2013 Dec;119(6):1422-33. doi: 10.1097/ALN.0000000000000013.
PubMed PMID: 24343288; PubMed Central PMCID: PMC4869072.


95: Kaunisto MA, Jokela R, Tallgren M, Kambur O, Tikkanen E, Tasmuth T, Sipilä R,
Palotie A, Estlander AM, Leidenius M, Ripatti S, Kalso EA. Pain in 1,000 women
treated for breast cancer: a prospective study of pain sensitivity and
postoperative pain. Anesthesiology. 2013 Dec;119(6):1410-21. doi:
10.1097/ALN.0000000000000012. PubMed PMID: 24343286.


96: Brubaker D, Difeo A, Chen Y, Pearl T, Zhai K, Bebek G, Chance M,
Barnholtz-Sloan J. Drug Intervention Response Predictions with PARADIGM (DIRPP)
identifies drug resistant cancer cell lines and pathway mechanisms of resistance.
Pac Symp Biocomput. 2014:125-35. PubMed PMID: 24297540; PubMed Central PMCID:
PMC4007508.


97: Lin WY, Brock IW, Connley D, Cramp H, Tucker R, Slate J, Reed MW,
Balasubramanian SP, Cannon-Albright LA, Camp NJ, Cox A. Associations of ATR and
CHEK1 single nucleotide polymorphisms with breast cancer. PLoS One. 2013 Jul
3;8(7):e68578. doi: 10.1371/journal.pone.0068578. Print 2013. PubMed PMID:
23844225; PubMed Central PMCID: PMC3700940.


98: Shah N, Jin K, Cruz LA, Park S, Sadik H, Cho S, Goswami CP, Nakshatri H,
Gupta R, Chang HY, Zhang Z, Cimino-Mathews A, Cope L, Umbricht C, Sukumar S.
HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by
suppressing ERα and inducing IL-6 expression. Cancer Res. 2013 Sep
1;73(17):5449-58. doi: 10.1158/0008-5472.CAN-13-1178. Epub 2013 Jul 5. PubMed
PMID: 23832664; PubMed Central PMCID: PMC3967590.


99: Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA, Coetzee GA.
Comprehensive functional annotation of seventy-one breast cancer risk Loci. PLoS 
One. 2013 May 22;8(5):e63925. doi: 10.1371/journal.pone.0063925. Print 2013.
PubMed PMID: 23717510; PubMed Central PMCID: PMC3661550.


100: Laddha SV, Nayak S, Paul D, Reddy R, Sharma C, Jha P, Hariharan M, Agrawal
A, Chowdhury S, Sarkar C, Mukhopadhyay A. Genome-wide analysis reveals
downregulation of miR-379/miR-656 cluster in human cancers. Biol Direct. 2013 Apr
24;8:10. doi: 10.1186/1745-6150-8-10. PubMed PMID: 23618224; PubMed Central
PMCID: PMC3680324.


101: Neuhauser N, Nagaraj N, McHardy P, Zanivan S, Scheltema R, Cox J, Mann M.
High performance computational analysis of large-scale proteome data sets to
assess incremental contribution to coverage of the human genome. J Proteome Res. 
2013 Jun 7;12(6):2858-68. doi: 10.1021/pr400181q. Epub 2013 May 6. PubMed PMID:
23611042.


102: Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL,
Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A,
Turnbull C, Rahman N; Breast and Ovarian Cancer Susceptibility Collaboration,
Fletcher O, Peto J, Gibson L, Dos Santos Silva I, Nevanlinna H, Muranen TA,
Aittomäki K, Blomqvist C, Czene K, Irwanto A, Liu J, Waisfisz Q, Meijers-Heijboer
H, Adank M; Hereditary Breast and Ovarian Cancer Research Group Netherlands
(HEBON), van der Luijt RB, Hein R, Dahmen N, Beckman L, Meindl A, Schmutzler RK, 
Müller-Myhsok B, Lichtner P, Hopper JL, Southey MC, Makalic E, Schmidt DF,
Uitterlinden AG, Hofman A, Hunter DJ, Chanock SJ, Vincent D, Bacot F, Tessier DC,
Canisius S, Wessels LF, Haiman CA, Shah M, Luben R, Brown J, Luccarini C, Schoof 
N, Humphreys K, Li J, Nordestgaard BG, Nielsen SF, Flyger H, Couch FJ, Wang X,
Vachon C, Stevens KN, Lambrechts D, Moisse M, Paridaens R, Christiaens MR,
Rudolph A, Nickels S, Flesch-Janys D, Johnson N, Aitken Z, Aaltonen K, Heikkinen 
T, Broeks A, Veer LJ, van der Schoot CE, Guénel P, Truong T, Laurent-Puig P,
Menegaux F, Marme F, Schneeweiss A, Sohn C, Burwinkel B, Zamora MP, Perez JI,
Pita G, Alonso MR, Cox A, Brock IW, Cross SS, Reed MW, Sawyer EJ, Tomlinson I,
Kerin MJ, Miller N, Henderson BE, Schumacher F, Le Marchand L, Andrulis IL,
Knight JA, Glendon G, Mulligan AM; kConFab Investigators; Australian Ovarian
Cancer Study Group, Lindblom A, Margolin S, Hooning MJ, Hollestelle A, van den
Ouweland AM, Jager A, Bui QM, Stone J, Dite GS, Apicella C, Tsimiklis H, Giles
GG, Severi G, Baglietto L, Fasching PA, Haeberle L, Ekici AB, Beckmann MW,
Brenner H, Müller H, Arndt V, Stegmaier C, Swerdlow A, Ashworth A, Orr N, Jones
M, Figueroa J, Lissowska J, Brinton L, Goldberg MS, Labrèche F, Dumont M,
Winqvist R, Pylkäs K, Jukkola-Vuorinen A, Grip M, Brauch H, Hamann U, Brüning T; 
GENICA (Gene Environment Interaction and Breast Cancer in Germany) Network,
Radice P, Peterlongo P, Manoukian S, Bonanni B, Devilee P, Tollenaar RA, Seynaeve
C, van Asperen CJ, Jakubowska A, Lubinski J, Jaworska K, Durda K, Mannermaa A,
Kataja V, Kosma VM, Hartikainen JM, Bogdanova NV, Antonenkova NN, Dörk T,
Kristensen VN, Anton-Culver H, Slager S, Toland AE, Edge S, Fostira F, Kang D,
Yoo KY, Noh DY, Matsuo K, Ito H, Iwata H, Sueta A, Wu AH, Tseng CC, Van Den Berg 
D, Stram DO, Shu XO, Lu W, Gao YT, Cai H, Teo SH, Yip CH, Phuah SY, Cornes BK,
Hartman M, Miao H, Lim WY, Sng JH, Muir K, Lophatananon A, Stewart-Brown S,
Siriwanarangsan P, Shen CY, Hsiung CN, Wu PE, Ding SL, Sangrajrang S, Gaborieau
V, Brennan P, McKay J, Blot WJ, Signorello LB, Cai Q, Zheng W, Deming-Halverson
S, Shrubsole M, Long J, Simard J, Garcia-Closas M, Pharoah PD, Chenevix-Trench G,
Dunning AM, Benitez J, Easton DF. Large-scale genotyping identifies 41 new loci
associated with breast cancer risk. Nat Genet. 2013 Apr;45(4):353-61, 361e1-2.
doi: 10.1038/ng.2563. PubMed PMID: 23535729; PubMed Central PMCID: PMC3771688.


103: Rosenfeld JA, Mason CE. Pervasive sequence patents cover the entire human
genome. Genome Med. 2013 Mar 25;5(3):27. doi: 10.1186/gm431. eCollection 2013.
PubMed PMID: 23522065; PubMed Central PMCID: PMC3706854.


104: Maggrah A, Robinson K, Creed J, Wittock R, Gehman K, Gehman T, Brown H,
Harbottle A, Froberg MK, Klein D, Reguly B, Parr R. Paired ductal carcinoma in
situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome
indicate a cancerization field effect. Biomed Res Int. 2013;2013:379438. doi:
10.1155/2013/379438. Epub 2012 Dec 26. PubMed PMID: 23509716; PubMed Central
PMCID: PMC3591154.


105: Mlakar V, Marc J. Highlights from the latest pharmacogenomic genome-wide
association studies. Pharmacogenomics. 2013 Mar;14(4):357-60. doi:
10.2217/pgs.13.17. PubMed PMID: 23438881.


106: Bermejo JL, Kabisch M, Dünnebier T, Schnaidt S, Melchior F, Fischer HP,
Harth V, Rabstein S, Pesch B, Brüning T, Justenhoven C, Brauch H, Baisch C, Ko
YD, Hamann U. Exploring the association between genetic variation in the SUMO
isopeptidase gene USPL1 and breast cancer through integration of data from the
population-based GENICA study and external genetic databases. Int J Cancer. 2013 
Jul 15;133(2):362-72. doi: 10.1002/ijc.28040. Epub 2013 Feb 25. PubMed PMID:
23338788.


107: Li J, Koh WP, Jin AZ, Yuan JM, Yu MC, Butler LM. Calcium intake is not
related to breast cancer risk among Singapore Chinese women. Int J Cancer. 2013
Aug 1;133(3):680-6. doi: 10.1002/ijc.28027. Epub 2013 Mar 13. PubMed PMID:
23319293; PubMed Central PMCID: PMC3727233.


108: Alkins R, Burgess A, Ganguly M, Francia G, Kerbel R, Wels WS, Hynynen K.
Focused ultrasound delivers targeted immune cells to metastatic brain tumors.
Cancer Res. 2013 Mar 15;73(6):1892-9. doi: 10.1158/0008-5472.CAN-12-2609. Epub
2013 Jan 9. PubMed PMID: 23302230; PubMed Central PMCID: PMC3607446.


109: Machiela MJ, Chen C, Liang L, Diver WR, Stevens VL, Tsilidis KK, Haiman CA, 
Chanock SJ, Hunter DJ, Kraft P; National Cancer Institute Breast and Prostate
Cancer Cohort Consortium. One thousand genomes imputation in the National Cancer 
Institute Breast and Prostate Cancer Cohort Consortium aggressive prostate cancer
genome-wide association study. Prostate. 2013 May;73(7):677-89. doi:
10.1002/pros.22608. Epub 2012 Dec 19. PubMed PMID: 23255287; PubMed Central
PMCID: PMC3962143.


110: Kabalar ME, Karaman A, Aylu B, Ozmen SA, Erdem I. Genetic alterations in
benign, preneoplastic and malignant breast lesions. Indian J Pathol Microbiol.
2012 Jul-Sep;55(3):319-25. doi: 10.4103/0377-4929.101737. PubMed PMID: 23032824.


111: Thompson ER, Doyle MA, Ryland GL, Rowley SM, Choong DY, Tothill RW, Thorne
H; kConFab, Barnes DR, Li J, Ellul J, Philip GK, Antill YC, James PA, Trainer AH,
Mitchell G, Campbell IG. Exome sequencing identifies rare deleterious mutations
in DNA repair genes FANCC and BLM as potential breast cancer susceptibility
alleles. PLoS Genet. 2012 Sep;8(9):e1002894. doi: 10.1371/journal.pgen.1002894.
Epub 2012 Sep 27. PubMed PMID: 23028338; PubMed Central PMCID: PMC3459953.


112: Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, Jorgensen JL,
de Peralta-Venturina M, Mustafa EB, Young KH, You MJ, Fayad LE, Blenc AM, Miranda
RN. Anaplastic large cell lymphoma associated with breast implants: a report of
13 cases. Am J Surg Pathol. 2012 Jul;36(7):1000-8. doi:
10.1097/PAS.0b013e31825749b1. PubMed PMID: 22613996.


113: Guo Y, Long J, He J, Li CI, Cai Q, Shu XO, Zheng W, Li C. Exome sequencing
generates high quality data in non-target regions. BMC Genomics. 2012 May
20;13:194. doi: 10.1186/1471-2164-13-194. PubMed PMID: 22607156; PubMed Central
PMCID: PMC3416685.


114: Chisholm KM, Aubert SD, Freese KP, Zakian VA, King MC, Welcsh PL. A
genomewide screen for suppressors of Alu-mediated rearrangements reveals a role
for PIF1. PLoS One. 2012;7(2):e30748. doi: 10.1371/journal.pone.0030748. Epub
2012 Feb 9. PubMed PMID: 22347400; PubMed Central PMCID: PMC3276492.


115: Chen G, Yin K, Shi L, Fang Y, Qi Y, Li P, Luo J, He B, Liu M, Shi T.
Comparative analysis of human protein-coding and noncoding RNAs between brain and
10 mixed cell lines by RNA-Seq. PLoS One. 2011;6(11):e28318. doi:
10.1371/journal.pone.0028318. Epub 2011 Nov 30. PubMed PMID: 22140575; PubMed
Central PMCID: PMC3227660.


116: Lorenzo Bermejo J, Garcia Perez A, Brandt A, Hemminki K, Matthews AG.
Comparison of six statistics of genetic association regarding their ability to
discriminate between causal variants and genetically linked markers. Hum Hered.
2011;72(2):142-52. doi: 10.1159/000332006. Epub 2011 Oct 19. PubMed PMID:
22025134.


117: Morris BA, Chambers SK, Campbell M, Dwyer M, Dunn J. Motorcycles and breast 
cancer: the influence of peer support and challenge on distress and posttraumatic
growth. Support Care Cancer. 2012 Aug;20(8):1849-58. doi:
10.1007/s00520-011-1287-5. Epub 2011 Oct 9. PubMed PMID: 21983863.


118: Lee P, Fu YP, Figueroa JD, Prokunina-Olsson L, Gonzalez-Bosquet J, Kraft P, 
Wang Z, Jacobs KB, Yeager M, Horner MJ, Hankinson SE, Hutchinson A, Chatterjee N,
Garcia-Closas M, Ziegler RG, Berg CD, Buys SS, McCarty CA, Feigelson HS, Thun MJ,
Diver R, Prentice R, Jackson R, Kooperberg C, Chlebowski R, Lissowska J,
Peplonska B, Brinton LA, Tucker M, Fraumeni JF Jr, Hoover RN, Thomas G, Hunter
DJ, Chanock SJ. Fine mapping of 14q24.1 breast cancer susceptibility locus. Hum
Genet. 2012 Mar;131(3):479-90. doi: 10.1007/s00439-011-1088-4. Epub 2011 Sep 30. 
PubMed PMID: 21959381; PubMed Central PMCID: PMC4159746.


119: Dearth RK, Kuiatse I, Wang YF, Liao L, Hilsenbeck SG, Brown PH, Xu J, Lee
AV. A moderate elevation of circulating levels of IGF-I does not alter ErbB2
induced mammary tumorigenesis. BMC Cancer. 2011 Aug 25;11:377. doi:
10.1186/1471-2407-11-377. PubMed PMID: 21867536; PubMed Central PMCID:
PMC3189189.


120: Cortés-Sempere M, Ibáñez de Cáceres I. microRNAs as novel epigenetic
biomarkers for human cancer. Clin Transl Oncol. 2011 Jun;13(6):357-62. doi:
10.1007/s12094-011-0668-z. PubMed PMID: 21680295.


121: Wang L, Zhang Q, Zhang J, Sun S, Guo H, Jia Z, Wang B, Shao Z, Wang Z, Hu X.
PI3K pathway activation results in low efficacy of both trastuzumab and
lapatinib. BMC Cancer. 2011 Jun 15;11:248. doi: 10.1186/1471-2407-11-248. PubMed 
PMID: 21676217; PubMed Central PMCID: PMC3141770.


122: Stegel V, Krajc M, Zgajnar J, Teugels E, De Grève J, Hočevar M, Novaković S.
The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian
population. BMC Med Genet. 2011 Jan 14;12:9. doi: 10.1186/1471-2350-12-9. PubMed 
PMID: 21232165; PubMed Central PMCID: PMC3025939.


123: Li L, Goedegebuure P, Mardis ER, Ellis MJ, Zhang X, Herndon JM, Fleming TP, 
Carreno BM, Hansen TH, Gillanders WE. Cancer genome sequencing and its
implications for personalized cancer vaccines. Cancers (Basel). 2011 Nov
25;3(4):4191-211. doi: 10.3390/cancers3044191. PubMed PMID: 24213133; PubMed
Central PMCID: PMC3763418.


124: Wang HF, Takenaka K, Nakanishi A, Miki Y. BRCA2 and nucleophosmin coregulate
centrosome amplification and form a complex with the Rho effector kinase ROCK2.
Cancer Res. 2011 Jan 1;71(1):68-77. doi: 10.1158/0008-5472.CAN-10-0030. Epub 2010
Nov 16. PubMed PMID: 21084279.


125: Ding YC, Steele L, Kuan CJ, Greilac S, Neuhausen SL. Mutations in BRCA2 and 
PALB2 in male breast cancer cases from the United States. Breast Cancer Res
Treat. 2011 Apr;126(3):771-8. doi: 10.1007/s10549-010-1195-2. Epub 2010 Oct 7.
PubMed PMID: 20927582; PubMed Central PMCID: PMC3059396.


126: Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A,
Jonasdottir A, Besenbacher S, Kostic JP, Fackenthal JD, Huo D, Adebamowo C,
Ogundiran T, Olson JE, Fredericksen ZS, Wang X, Look MP, Sieuwerts AM, Martens
JW, Pajares I, Garcia-Prats MD, Ramon-Cajal JM, de Juan A, Panadero A, Ortega E, 
Aben KK, Vermeulen SH, Asadzadeh F, van Engelenburg KC, Margolin S, Shen CY, Wu
PE, Försti A, Lenner P, Henriksson R, Johansson R, Enquist K, Hallmans G, Jonsson
T, Sigurdsson H, Alexiusdottir K, Gudmundsson J, Sigurdsson A, Frigge ML,
Gudmundsson L, Kristjansson K, Halldorsson BV, Styrkarsdottir U, Gulcher JR,
Hemminki K, Lindblom A, Kiemeney LA, Mayordomo JI, Foekens JA, Couch FJ, Olopade 
OI, Gudbjartsson DF, Thorsteinsdottir U, Rafnar T, Johannsson OT, Stefansson K.
Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer
susceptibility locus. PLoS Genet. 2010 Jul 22;6(7):e1001029. doi:
10.1371/journal.pgen.1001029. PubMed PMID: 20661439; PubMed Central PMCID:
PMC2908678.


127: Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S,
Gariboldi M, Pierotti MA, Daidone MG. Gene expression analysis reveals a
different transcriptomic landscape in female and male breast cancer. Breast
Cancer Res Treat. 2011 Jun;127(3):601-10. doi: 10.1007/s10549-010-1015-8. Epub
2010 Jul 13. PubMed PMID: 20625818.


128: Bentz EK, Pils D, Bilban M, Kaufmann U, Hefler LA, Reinthaller A, Singer CF,
Huber JC, Horvat R, Tempfer CB. Gene expression signatures of breast tissue
before and after cross-sex hormone therapy in female-to-male transsexuals. Fertil
Steril. 2010 Dec;94(7):2688-96. doi: 10.1016/j.fertnstert.2010.04.024. Epub 2010 
May 26. PubMed PMID: 20537635.


129: Barrios CH, Liu MC, Lee SC, Vanlemmens L, Ferrero JM, Tabei T, Pivot X,
Iwata H, Aogi K, Lugo-Quintana R, Harbeck N, Brickman MJ, Zhang K, Kern KA,
Martin M. Phase III randomized trial of sunitinib versus capecitabine in patients
with previously treated HER2-negative advanced breast cancer. Breast Cancer Res
Treat. 2010 May;121(1):121-31. doi: 10.1007/s10549-010-0788-0. Epub 2010 Mar 26. 
PubMed PMID: 20339913; PubMed Central PMCID: PMC2855860.


130: Wolff AC, Wang M, Li H, Pins MR, Pretorius FJ, Rowland KM, Sparano JA,
Davidson NE. Phase II trial of pegylated liposomal doxorubicin plus docetaxel
with and without trastuzumab in metastatic breast cancer: Eastern Cooperative
Oncology Group trial E3198. Breast Cancer Res Treat. 2010 May;121(1):111-20. doi:
10.1007/s10549-010-0838-7. Epub 2010 Mar 24. PubMed PMID: 20333545; PubMed
Central PMCID: PMC3112234.


131: Evans DG, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo
F. Long-term outcomes of breast cancer in women aged 30 years or younger, based
on family history, pathology and BRCA1/BRCA2/TP53 status. Br J Cancer. 2010 Mar
30;102(7):1091-8. doi: 10.1038/sj.bjc.6605606. Epub 2010 Mar 16. PubMed PMID:
20234365; PubMed Central PMCID: PMC2853095.


132: Haibe-Kains B, Desmedt C, Rothé F, Piccart M, Sotiriou C, Bontempi G. A
fuzzy gene expression-based computational approach improves breast cancer
prognostication. Genome Biol. 2010;11(2):R18. doi: 10.1186/gb-2010-11-2-r18. Epub
2010 Feb 15. PubMed PMID: 20156340; PubMed Central PMCID: PMC2872878.


133: Metzger Filho O, Ignatiadis M, Sotiriou C. Genomic Grade Index: An important
tool for assessing breast cancer tumor grade and prognosis. Crit Rev Oncol
Hematol. 2011 Jan;77(1):20-9. doi: 10.1016/j.critrevonc.2010.01.011. Review.
PubMed PMID: 20138540.


134: Buness A, Ruschhaupt M, Kuner R, Tresch A. Classification across gene
expression microarray studies. BMC Bioinformatics. 2009 Dec 30;10:453. doi:
10.1186/1471-2105-10-453. PubMed PMID: 20042109; PubMed Central PMCID:
PMC2811711.


135: Kiely BE, Jenkins MA, McKinley JM, Friedlander ML, Weideman P, Milne RL,
McLachlan SA, Hopper JL, Phillips KA. Contralateral risk-reducing mastectomy in
BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen
Cuningham Foundation Consortium for Research into Familial Breast Cancer
(kConFab). Breast Cancer Res Treat. 2010 Apr;120(3):715-23. doi:
10.1007/s10549-009-0497-8. Epub 2009 Aug 11. Erratum in: Breast Cancer Res Treat.
2010 Apr;120(3):725-6. PubMed PMID: 19669874.


136: Mason SA, Cozzi SJ, Pierce CJ, Pavey SJ, Parsons PG, Boyle GM. The induction
of senescence-like growth arrest by protein kinase C-activating diterpene esters 
in solid tumor cells. Invest New Drugs. 2010 Oct;28(5):575-86. doi:
10.1007/s10637-009-9292-y. Epub 2009 Jul 28. PubMed PMID: 19636513.


137: Shah P, Rosen M, Stopfer J, Siegfried J, Kaltman R, Mason B, Armstrong K,
Nathanson KL, Schnall M, Domchek SM. Prospective study of breast MRI in BRCA1 and
BRCA2 mutation carriers: effect of mutation status on cancer incidence. Breast
Cancer Res Treat. 2009 Dec;118(3):539-46. doi: 10.1007/s10549-009-0475-1. Epub
2009 Jul 17. PubMed PMID: 19609668; PubMed Central PMCID: PMC3342814.


138: Marella NV, Malyavantham KS, Wang J, Matsui S, Liang P, Berezney R.
Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer 
progression cell lines. Cancer Res. 2009 Jul 15;69(14):5946-53. doi:
10.1158/0008-5472.CAN-09-0420. Epub 2009 Jul 7. Erratum in: Cancer Res. 2009 Oct 
1;69(19):7894. PubMed PMID: 19584277; PubMed Central PMCID: PMC2826242.


139: Summers KM, Bokil NJ, Baisden JM, West MJ, Sweet MJ, Raggatt LJ, Hume DA.
Experimental and bioinformatic characterisation of the promoter region of the
Marfan syndrome gene, FBN1. Genomics. 2009 Oct;94(4):233-40. doi:
10.1016/j.ygeno.2009.06.005. Epub 2009 Jun 30. PubMed PMID: 19573590.


140: Evans DG, Lennard F, Pointon LJ, Ramus SJ, Gayther SA, Sodha N, Kwan-Lim GE,
Leach MO, Warren R, Thompson D, Easton DF, Eeles R; UK Study of MRI Screening for
Breast Cancer in Women at High Risk (MARIBS). Eligibility for magnetic resonance 
imaging screening in the United Kingdom: effect of strict selection criteria and 
anonymous DNA testing on breast cancer incidence in the MARIBS Study. Cancer
Epidemiol Biomarkers Prev. 2009 Jul;18(7):2123-31. doi:
10.1158/1055-9965.EPI-09-0138. Epub 2009 Jun 30. PubMed PMID: 19567506; PubMed
Central PMCID: PMC2869031.


141: Khoshnaw SM, Green AR, Powe DG, Ellis IO. MicroRNA involvement in the
pathogenesis and management of breast cancer. J Clin Pathol. 2009
May;62(5):422-8. doi: 10.1136/jcp.2008.060681. Review. PubMed PMID: 19398594.


142: Islam MM, Sattar MA, Amin MF, Yao X, Murase K. A new adaptive merging and
growing algorithm for designing artificial neural networks. IEEE Trans Syst Man
Cybern B Cybern. 2009 Jun;39(3):705-22. doi: 10.1109/TSMCB.2008.2008724. Epub
2009 Feb 6. PubMed PMID: 19203888.


143: Dip R, Lenz S, Gmuender H, Naegeli H. Pleiotropic combinatorial
transcriptomes of human breast cancer cells exposed to mixtures of dietary
phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95. doi:
10.1016/j.fct.2009.01.008. Epub 2009 Jan 9. PubMed PMID: 19167446.


144: Fortuny D, Balmaña J, Graña B, Torres A, Ramón y Cajal T, Darder E, Gadea N,
Velasco A, López C, Sanz J, Alonso C, Brunet J. Opinion about reproductive
decision making among individuals undergoing BRCA1/2 genetic testing in a
multicentre Spanish cohort. Hum Reprod. 2009 Apr;24(4):1000-6. doi:
10.1093/humrep/den471. Epub 2008 Dec 26. Erratum in: Hum Reprod. 2009
Jul;24(7):1772. PubMed PMID: 19112076.


145: Wegman PP, Marcus NJ, Malakkaran BP, Wingren S. Biological significance of
allele specific loss of the p53 gene in breast carcinomas. Breast Cancer Res
Treat. 2009 Nov;118(1):15-20. doi: 10.1007/s10549-008-0212-1. Epub 2008 Oct 14.
PubMed PMID: 18853251.


146: Krajc M, Teugels E, Zgajnar J, Goelen G, Besic N, Novakovic S, Hocevar M, De
Grève J. Five recurrent BRCA1/2 mutations are responsible for cancer
predisposition in the majority of Slovenian breast cancer families. BMC Med
Genet. 2008 Sep 10;9:83. doi: 10.1186/1471-2350-9-83. PubMed PMID: 18783588;
PubMed Central PMCID: PMC2547096.


147: Byrd LM, Shenton A, Maher ER, Woodward E, Belk R, Lim C, Lalloo F, Howell A,
Jayson GC, Evans GD. Better life expectancy in women with BRCA2 compared with
BRCA1 mutations is attributable to lower frequency and later onset of ovarian
cancer. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1535-42. doi:
10.1158/1055-9965.EPI-07-2792. PubMed PMID: 18559571.


148: Hait WN, Yang JM. The individualization of cancer therapy: the unexpected
role of p53. Trans Am Clin Climatol Assoc. 2006;117:85-101; discussion 101.
Review. PubMed PMID: 18528466; PubMed Central PMCID: PMC1500917.


149: Wu X, Jiang R, Zhang MQ, Li S. Network-based global inference of human
disease genes. Mol Syst Biol. 2008;4:189. doi: 10.1038/msb.2008.27. Epub 2008 May
6. PubMed PMID: 18463613; PubMed Central PMCID: PMC2424293.


150: Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N,
Kwiatkowski F, Chalabi N, Satih S, Bignon YJ. DNA repair gene ERCC2 polymorphisms
and associations with breast and ovarian cancer risk. Mol Cancer. 2008 May
2;7:36. doi: 10.1186/1476-4598-7-36. PubMed PMID: 18454848; PubMed Central PMCID:
PMC2394522.


151: Larsimont D, Durbecq V, Awada A, Di Leo A. [HER2 and topoisomerase II alpha:
useful clinical markers in breast cancer]. Bull Cancer. 2008 Mar;95(3):344-51.
doi: 10.1684/bdc.2008.0596. Review. French. PubMed PMID: 18390415.


152: Han HJ, Russo J, Kohwi Y, Kohwi-Shigematsu T. SATB1 reprogrammes gene
expression to promote breast tumour growth and metastasis. Nature. 2008 Mar
13;452(7184):187-93. doi: 10.1038/nature06781. PubMed PMID: 18337816.


153: Kunej T, Wang Z, Michal JJ, Daniels TF, Magnuson NS, Jiang Z. Functional
UQCRC1 polymorphisms affect promoter activity and body lipid accumulation.
Obesity (Silver Spring). 2007 Dec;15(12):2896-901. doi: 10.1038/oby.2007.344.
PubMed PMID: 18198295.


154: Hu G, Yang Q, Cui X, Yue G, Azaro MA, Wang HY, Li H. A highly sensitive and 
specific system for large-scale gene expression profiling. BMC Genomics. 2008 Jan
10;9:9. doi: 10.1186/1471-2164-9-9. PubMed PMID: 18186939; PubMed Central PMCID: 
PMC2267712.


155: Cross DS, Burmester JK. Functional characterization of the HOXB13 promoter
region. Med Oncol. 2008;25(3):287-93. Epub 2007 Dec 28. PubMed PMID: 18163187.


156: Rokavec M, Justenhoven C, Schroth W, Istrate MA, Haas S, Fischer HP,
Vollmert C, Illig T, Hamann U, Ko YD, Glavac D, Brauch H. A novel polymorphism in
the promoter region of ERBB4 is associated with breast and colorectal cancer
risk. Clin Cancer Res. 2007 Dec 15;13(24):7506-14. PubMed PMID: 18094435.


157: Ingraham BA, Bragdon B, Nohe A. Molecular basis of the potential of vitamin 
D to prevent cancer. Curr Med Res Opin. 2008 Jan;24(1):139-49. Review. PubMed
PMID: 18034918.


158: Lobo C, Lopes G, Silva O, Gluck S. Paclitaxel albumin-bound particles
(abraxane) in combination with bevacizumab with or without gemcitabine: early
experience at the University of Miami/Braman Family Breast Cancer Institute.
Biomed Pharmacother. 2007 Oct;61(9):531-3. Epub 2007 Sep 12. PubMed PMID:
17913443.


159: Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T, Lo PK, Zhang X, Sukumar S.
HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to 
retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 2007 Sep
1;67(17):8007-13. PubMed PMID: 17804711.


160: Dinh P, Sotiriou C, Piccart MJ. The evolution of treatment strategies:
aiming at the target. Breast. 2007 Dec;16 Suppl 2:S10-6. Epub 2007 Aug 30.
Review. PubMed PMID: 17764940.


161: Widakowich C, de Azambuja E, Gil T, Cardoso F, Dinh P, Awada A,
Piccart-Gebhart M. Molecular targeted therapies in breast cancer: where are we
now? Int J Biochem Cell Biol. 2007;39(7-8):1375-87. Epub 2007 May 4. Review.
PubMed PMID: 17543572.


162: Millar JA, Millward MJ. Cost effectiveness of trastuzumab in the adjuvant
treatment of early breast cancer: a lifetime model. Pharmacoeconomics.
2007;25(5):429-42. PubMed PMID: 17488140.


163: Brandes JC, Carraway H, Herman JG. Optimal primer design using the novel
primer design program: MSPprimer provides accurate methylation analysis of the
ATM promoter. Oncogene. 2007 Sep 13;26(42):6229-37. Epub 2007 Mar 26. Erratum in:
Oncogene. 2007 Oct 11;26(46):6684. PubMed PMID: 17384671.


164: Gallo D, Jacquemotte F, Cleeren A, Laïos I, Hadiy S, Rowlands MG, Caille O, 
Nonclercq D, Laurent G, Jacquot Y, Leclercq G. Calmodulin-independent, agonistic 
properties of a peptide containing the calmodulin binding site of estrogen
receptor alpha. Mol Cell Endocrinol. 2007 Mar 30;268(1-2):37-49. Epub 2007 Jan
25. PubMed PMID: 17316976.


165: Osorio A, Milne RL, Honrado E, Barroso A, Diez O, Salazar R, de la Hoya M,
Vega A, Benítez J. Classification of missense variants of unknown significance in
BRCA1 based on clinical and tumor information. Hum Mutat. 2007 May;28(5):477-85. 
PubMed PMID: 17279547.


166: Giuliani R, Durbecq V, Di Leo A, Paesmans M, Larsimont D, Leroy JY, Borms M,
Vindevoghel A, Jerusalem G, D'Hondt V, Dirix L, Canon JL, Richard V, Cocquyt V,
Majois F, Reginster M, Demol J, Kains JP, Delree P, Keppens C, Sotiriou C,
Piccart MJ, Cardoso F. Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene
amplification as predictive factors of response to trastuzumab in patients with
HER-2 overexpressing metastatic breast cancer (MBC). Eur J Cancer. 2007
Mar;43(4):725-35. Epub 2007 Jan 23. PubMed PMID: 17251007.


167: Creighton CJ. A gene transcription signature of the Akt/mTOR pathway in
clinical breast tumors. Oncogene. 2007 Jul 12;26(32):4648-55. Epub 2007 Jan 8.
PubMed PMID: 17213801.


168: Mano MS, Rosa DD, De Azambuja E, Ismael GF, Durbecq V. The 17q12-q21
amplicon: Her2 and topoisomerase-IIalpha and their importance to the biology of
solid tumours. Cancer Treat Rev. 2007 Feb;33(1):64-77. Epub 2006 Nov 17. Review. 
PubMed PMID: 17113234.


169: Schmutzler RK, Rhiem K, Breuer P, Wardelmann E, Lehnert M, Coburger S,
Wappenschmidt B. Outcome of a structured surveillance programme in women with a
familial predisposition for breast cancer. Eur J Cancer Prev. 2006
Dec;15(6):483-9. PubMed PMID: 17106326.


170: Liebens FP, Carly B, Pastijn A, Rozenberg S. Management of BRCA1/2
associated breast cancer: a systematic qualitative review of the state of
knowledge in 2006. Eur J Cancer. 2007 Jan;43(2):238-57. Epub 2006 Nov 13. Review.
PubMed PMID: 17095205.


171: Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A 
polymorphism imparts maternal Haplogroup N a risk for breast and esophageal
cancer. Cancer Lett. 2007 May 8;249(2):249-55. Epub 2006 Nov 1. PubMed PMID:
17081685.


172: Piccart-Gebhart MJ. Adjuvant trastuzumab therapy for HER2-overexpressing
breast cancer: what we know and what we still need to learn. Eur J Cancer. 2006
Aug;42(12):1715-9. Epub 2006 Jun 27. Review. PubMed PMID: 16806901.


173: Muradrasoli S, Forsman A, Hu L, Blikstad V, Blomberg J. Development of
real-time PCRs for detection and quantitation of human MMTV-like (HML) sequences 
HML expression in human tissues. J Virol Methods. 2006 Sep;136(1-2):83-92. Epub
2006 May 19. PubMed PMID: 16713632.


174: Batrakova EV, Kelly DL, Li S, Li Y, Yang Z, Xiao L, Alakhova DY, Sherman S, 
Alakhov VY, Kabanov AV. Alteration of genomic responses to doxorubicin and
prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85.
Mol Pharm. 2006 Mar-Apr;3(2):113-23. PubMed PMID: 16579640; PubMed Central PMCID:
PMC2566789.


175: Swift-Scanlan T, Blackford A, Argani P, Sukumar S, Fackler MJ. Two-color
quantitative multiplex methylation-specific PCR. Biotechniques. 2006
Feb;40(2):210-9. PubMed PMID: 16526411.


176: Heikkinen K, Rapakko K, Karppinen SM, Erkko H, Knuutila S, Lundán T,
Mannermaa A, Børresen-Dale AL, Borg A, Barkardottir RB, Petrini J, Winqvist R.
RAD50 and NBS1 are breast cancer susceptibility genes associated with genomic
instability. Carcinogenesis. 2006 Aug;27(8):1593-9. Epub 2006 Feb 12. PubMed
PMID: 16474176; PubMed Central PMCID: PMC3006189.


177: Mitchell G, Antill YC, Murray W, Kirk J, Salisbury E, Lindeman GJ, Di Iulio 
J, Milner AD, Devereaux L, Phillips KA. Nipple aspiration and ductal lavage in
women with a germline BRCA1 or BRCA2 mutation. Breast Cancer Res.
2005;7(6):R1122-31. Epub 2005 Nov 14. PubMed PMID: 16457692; PubMed Central
PMCID: PMC1410769.


178: Li J, Harris L, Mamon H, Kulke MH, Liu WH, Zhu P, Mike Makrigiorgos G. Whole
genome amplification of plasma-circulating DNA enables expanded screening for
allelic imbalance in plasma. J Mol Diagn. 2006 Feb;8(1):22-30. PubMed PMID:
16436631; PubMed Central PMCID: PMC1867563.


179: Donadio M, Ardine M, Berruti A, Beano A, Bottini A, Mistrangelo M, Bonardi
S, Castiglione F, Generali D, Polimeni MA, Bretti S, Alabiso O, Bertetto O;
Piemonte Oncology Network. Weekly cisplatin plus capecitabine in metastatic
breast cancer patients heavily pretreated with both anthracycline and taxanes.
Oncology. 2005;69(5):408-13. Epub 2005 Nov 24. PubMed PMID: 16319512.


180: Suh YJ, Chada S, McKenzie T, Liu Y, Swisher SG, Lucci A, Hunt KK.
Synergistic tumoricidal effect between celecoxib and adenoviral-mediated delivery
of mda-7 in human breast cancer cells. Surgery. 2005 Sep;138(3):422-30. PubMed
PMID: 16213894.


181: Varga D, Michel I, Patino-Garcia B, Paiss T, Vogel W, Maier C.
Radiosensitivity detected by the micronucleus test is not generally increased in 
sporadic prostate cancer patients. Cytogenet Genome Res. 2005;111(1):41-5. PubMed
PMID: 16093719.


182: Nagy A, Schally AV. Targeting of cytotoxic luteinizing hormone-releasing
hormone analogs to breast, ovarian, endometrial, and prostate cancers. Biol
Reprod. 2005 Nov;73(5):851-9. Epub 2005 Jul 20. Review. PubMed PMID: 16033997.


183: Wárlám-Rodenhuis CC, Koot VC, van der Luijt RB, Vasen HF, Ausems MG. A
prospective study on predictive factors linked to the presence of BRCA1 and BRCA2
mutations in breast cancer patients. Eur J Cancer. 2005 Jul;41(10):1409-15.
PubMed PMID: 15955690.


184: Lovelock PK, Healey S, Au W, Sum EY, Tesoriero A, Wong EM, Hinson S,
Brinkworth R, Bekessy A, Diez O, Izatt L, Solomon E, Jenkins M, Renard H, Hopper 
J, Waring P, Tavtigian SV, Goldgar D, Lindeman GJ, Visvader JE, Couch FJ,
Henderson BR, Southey M, Chenevix-Trench G, Spurdle AB, Brown MA; kConFab
Investigators. Genetic, functional, and histopathological evaluation of two
C-terminal BRCA1 missense variants. J Med Genet. 2006 Jan;43(1):74-83. Epub 2005 
May 27. PubMed PMID: 15923272; PubMed Central PMCID: PMC2564506.


185: Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the
1q minimal region of genomic gain in multiple cancers. Oncogene. 2005 Jul
14;24(30):4741-53. PubMed PMID: 15897902.


186: Laïos I, Journé F, Nonclercq D, Vidal DS, Toillon RA, Laurent G, Leclercq G.
Role of the proteasome in the regulation of estrogen receptor alpha turnover and 
function in MCF-7 breast carcinoma cells. J Steroid Biochem Mol Biol. 2005
Mar;94(4):347-59. PubMed PMID: 15857754.


187: Chen H, Rubin E, Zhang H, Chung S, Jie CC, Garrett E, Biswal S, Sukumar S.
Identification of transcriptional targets of HOXA5. J Biol Chem. 2005 May
13;280(19):19373-80. Epub 2005 Mar 9. PubMed PMID: 15757903.


188: Agoston AT, Argani P, Yegnasubramanian S, De Marzo AM, Ansari-Lari MA, Hicks
JL, Davidson NE, Nelson WG. Increased protein stability causes DNA
methyltransferase 1 dysregulation in breast cancer. J Biol Chem. 2005 May
6;280(18):18302-10. Epub 2005 Mar 8. Erratum in: J Biol Chem. 2005 Aug
5;280(31):28828. PubMed PMID: 15755728.


189: Loi S, Desmedt C, Cardoso F, Piccart M, Sotiriou C. Breast cancer gene
expression profiling: clinical trial and practice implications. Pharmacogenomics.
2005 Jan;6(1):49-58. Review. PubMed PMID: 15723605.


190: Simeone AM, Deng CX, Kelloff GJ, Steele VE, Johnson MM, Tari AM.
N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in
inhibiting the growth of BRCA1-mutated breast cancer cells. Carcinogenesis. 2005 
May;26(5):1000-7. Epub 2005 Feb 3. PubMed PMID: 15695235.


191: Loi S, Buyse M, Sotiriou C, Cardoso F. Challenges in breast cancer clinical 
trial design in the postgenomic era. Curr Opin Oncol. 2004 Nov;16(6):536-41.
Review. PubMed PMID: 15627014.


192: Rubinstein WS. Hereditary breast cancer in Jews. Fam Cancer.
2004;3(3-4):249-57. Review. PubMed PMID: 15516849.


193: Tynan SH, Lundeen SG, Allan GF. Cell type-specific bidirectional regulation 
of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. J Steroid
Biochem Mol Biol. 2004 Aug;91(4-5):225-39. PubMed PMID: 15336700.


194: Lee CH, Macgregor PF. Using microarrays to predict resistance to
chemotherapy in cancer patients. Pharmacogenomics. 2004 Sep;5(6):611-25. Review. 
PubMed PMID: 15335284.


195: Mano MS, Awada A, Minisini A, Durbecq V, Di Leo A, Piccart M. Exquisite
antitumour response to trastuzumab in a patient with no evidence of Ras-Raf-MAPK 
and PI3K-Akt pathways activation. Breast. 2004 Aug;13(4):347-9. PubMed PMID:
15325672.


196: Fackler MJ, McVeigh M, Mehrotra J, Blum MA, Lange J, Lapides A, Garrett E,
Argani P, Sukumar S. Quantitative multiplex methylation-specific PCR assay for
the detection of promoter hypermethylation in multiple genes in breast cancer.
Cancer Res. 2004 Jul 1;64(13):4442-52. PubMed PMID: 15231653.


197: Lacroix M, Leclercq G. About GATA3, HNF3A, and XBP1, three genes
co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer. Mol 
Cell Endocrinol. 2004 Apr 30;219(1-2):1-7. PubMed PMID: 15149721.


198: Dong Y, Roberge JY, Wang Z, Wang X, Tamasi J, Dell V, Golla R, Corte JR, Liu
Y, Fang T, Anthony MN, Schnur DM, Agler ML, Dickson JK Jr, Lawrence RM, Prack MM,
Seethala R, Feyen JH. Characterization of a new class of selective nonsteroidal
progesterone receptor agonists. Steroids. 2004 Mar;69(3):201-17. PubMed PMID:
15072922.


199: Hu WX, Zeng ZJ, Luo SQ, Chen Q. Suicide gene therapy of human breast cancer 
in SCID mice model by the regulation of Tet-On. Chin Med J (Engl). 2004
Mar;117(3):434-9. PubMed PMID: 15043787.


200: David GL, Yegnasubramanian S, Kumar A, Marchi VL, De Marzo AM, Lin X, Nelson
WG. MDR1 promoter hypermethylation in MCF-7 human breast cancer cells: changes in
chromatin structure induced by treatment with 5-Aza-cytidine. Cancer Biol Ther.
2004 Jun;3(6):540-8. Epub 2004 Jun 10. PubMed PMID: 15034303.


201: Chen H, Chung S, Sukumar S. HOXA5-induced apoptosis in breast cancer cells
is mediated by caspases 2 and 8. Mol Cell Biol. 2004 Jan;24(2):924-35. PubMed
PMID: 14701762; PubMed Central PMCID: PMC343791.


202: Ribeiro-Silva A, Ramalho LN, Garcia SB, Zucoloto S. Does the correlation
between EBNA-1 and p63 expression in breast carcinomas provide a clue to
tumorigenesis in Epstein-Barr virus-related breast malignancies? Braz J Med Biol 
Res. 2004 Jan;37(1):89-95. Epub 2003 Dec 18. PubMed PMID: 14689049.


203: Geisler S, Børresen-Dale AL, Johnsen H, Aas T, Geisler J, Akslen LA, Anker
G, Lønning PE. TP53 gene mutations predict the response to neoadjuvant treatment 
with 5-fluorouracil and mitomycin in locally advanced breast cancer. Clin Cancer 
Res. 2003 Nov 15;9(15):5582-8. PubMed PMID: 14654539.


204: Li Y, Chen Y, Dilley J, Arroyo T, Ko D, Working P, Yu DC. Carcinoembryonic
antigen-producing cell-specific oncolytic adenovirus, OV798, for colorectal
cancer therapy. Mol Cancer Ther. 2003 Oct;2(10):1003-9. PubMed PMID: 14578465.


205: Papadakis EN, Dokianakis DN, Spandidos DA. Genetic analysis of H-ras
intron-1 polymorphic and variable tandem repeat regions in human breast cancer.
Int J Biol Markers. 2003 Jul-Sep;18(3):195-9. PubMed PMID: 14535590.


206: Tryggvadottir L, Olafsdottir EJ, Gudlaugsdottir S, Thorlacius S, Jonasson
JG, Tulinius H, Eyfjord JE. BRCA2 mutation carriers, reproductive factors and
breast cancer risk. Breast Cancer Res. 2003;5(5):R121-8. Epub 2003 Jun 24. PubMed
PMID: 12927042; PubMed Central PMCID: PMC314423.


207: Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, Timms J,
Rowlands D, McConkey C, Reynolds GM, Ghataura S, England D, Caroll R, Young LS.
Reactivity with A monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen
1 defines a subset of aggressive breast cancers in the absence of the EBV genome.
Cancer Res. 2003 May 1;63(9):2338-43. PubMed PMID: 12727860.


208: Miederer M, Seidl C, Beyer GJ, Charlton DE, Vranjes-Duric S, Comor JJ, Huber
R, Nikula T, Apostolidis C, Schuhmacher C, Becker KF, Senekowitsch-Schmidtke R.
Comparison of the radiotoxicity of two alpha-particle-emitting immunoconjugates, 
terbium-149 and bismuth-213, directed against a tumor-specific, exon 9 deleted
(d9) E-cadherin adhesion protein. Radiat Res. 2003 May;159(5):612-20. PubMed
PMID: 12710872.


209: Binley K, Askham Z, Martin L, Spearman H, Day D, Kingsman S, Naylor S.
Hypoxia-mediated tumour targeting. Gene Ther. 2003 Apr;10(7):540-9. PubMed PMID: 
12646859.


210: Mukherjee B, Zhao H, Parashar B, Sood BM, Mahadevia PS, Klinger HP, Vikram
B, Achary MP. Microsatellite dinucleotide (T-G) repeat: a candidate DNA marker
for breast metastasis. Cancer Detect Prev. 2003;27(1):19-23. PubMed PMID:
12600413.


211: Lage JM, Leamon JH, Pejovic T, Hamann S, Lacey M, Dillon D, Segraves R,
Vossbrinck B, González A, Pinkel D, Albertson DG, Costa J, Lizardi PM. Whole
genome analysis of genetic alterations in small DNA samples using hyperbranched
strand displacement amplification and array-CGH. Genome Res. 2003
Feb;13(2):294-307. PubMed PMID: 12566408; PubMed Central PMCID: PMC420367.


212: Darbre PD, Byford JR, Shaw LE, Hall S, Coldham NG, Pope GS, Sauer MJ.
Oestrogenic activity of benzylparaben. J Appl Toxicol. 2003 Jan-Feb;23(1):43-51. 
PubMed PMID: 12518336.


213: Krajc M, De Grève J, Goelen G, Teugels E. BRCA2 founder mutation in
Slovenian breast cancer families. Eur J Hum Genet. 2002 Dec;10(12):879-82. PubMed
PMID: 12461697.


214: Cardoso F, Piccart MJ, Durbecq V, Di Leo A. Resistance to trastuzumab: a
necessary evil or a temporary challenge? Clin Breast Cancer. 2002
Oct;3(4):247-57; discussion 258-9. Review. PubMed PMID: 12425752.


215: Alderson R, Gohari-Fritsch S, Olsen H, Roschke V, Vance C, Connolly K. In
vitro and in vivo effects of repifermin (keratinocyte growth factor-2, KGF-2) on 
human carcinoma cells. Cancer Chemother Pharmacol. 2002 Sep;50(3):202-12. Epub
2002 Jul 30. PubMed PMID: 12203102.


216: Muller P, Kietz S, Gustafsson JA, Strom A. The anti-estrogenic effect of
all-trans-retinoic acid on the breast cancer cell line MCF-7 is dependent on
HES-1 expression. J Biol Chem. 2002 Aug 9;277(32):28376-9. Epub 2002 Jun 21.
PubMed PMID: 12080040.


217: Armstrong K, Weber B, Ubel PA, Guerra C, Schwartz JS. Interest in BRCA1/2
testing in a primary care population. Prev Med. 2002 Jun;34(6):590-5. PubMed
PMID: 12052018.


218: Bertucci F, Nasser V, Granjeaud S, Eisinger F, Adelaïde J, Tagett R, Loriod 
B, Giaconia A, Benziane A, Devilard E, Jacquemier J, Viens P, Nguyen C, Birnbaum 
D, Houlgatte R. Gene expression profiles of poor-prognosis primary breast cancer 
correlate with survival. Hum Mol Genet. 2002 Apr 15;11(8):863-72. PubMed PMID:
11971868.


219: Gancberg D, Di Leo A, Rouas G, Järvinen T, Verhest A, Isola J, Piccart MJ,
Larsimont D. Reliability of the tissue microarray based FISH for evaluation of
the HER-2 oncogene in breast carcinoma. J Clin Pathol. 2002 Apr;55(4):315-7.
PubMed PMID: 11919221; PubMed Central PMCID: PMC1769624.


220: Zierau O, Bodinet C, Kolba S, Wulf M, Vollmer G. Antiestrogenic activities
of Cimicifuga racemosa extracts. J Steroid Biochem Mol Biol. 2002
Jan;80(1):125-30. PubMed PMID: 11867271.


221: Wilson VS, Bobseine K, Lambright CR, Gray LE Jr. A novel cell line, MDA-kb2,
that stably expresses an androgen- and glucocorticoid-responsive reporter for the
detection of hormone receptor agonists and antagonists. Toxicol Sci. 2002
Mar;66(1):69-81. PubMed PMID: 11861974.


222: Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T,
Syrjäkoski K, Krahe R, Huusko P, Pyrhönen S, Holli K, Kallioniemi OP, Egilsson V,
Kere J, Nevanlinna H. Haplotype analysis in Icelandic and Finnish BRCA2 999del5
breast cancer families. Eur J Hum Genet. 2001 Oct;9(10):773-9. PubMed PMID:
11781689.


223: Zhong S, Yeo W, Tang MW, Lin XR, Mo F, Ho WM, Hui P, Johnson PJ. Gross
elevation of TT virus genome load in the peripheral blood mononuclear cells of
cancer patients. Ann N Y Acad Sci. 2001 Sep;945:84-92. PubMed PMID: 11708500.


224: Dörk T, Bendix R, Bremer M, Rades D, Klöpper K, Nicke M, Skawran B, Hector
A, Yamini P, Steinmann D, Weise S, Stuhrmann M, Karstens JH. Spectrum of ATM gene
mutations in a hospital-based series of unselected breast cancer patients. Cancer
Res. 2001 Oct 15;61(20):7608-15. PubMed PMID: 11606401.


225: Sankaranarayanan K, Chakraborty R. Impact of cancer predisposition and
radiosensitivity on the population risk of radiation-induced cancers. Radiat Res.
2001 Nov;156(5 Pt 2):648-56. PubMed PMID: 11604087.


226: Schmitt E, Dekant W, Stopper H. Assaying the estrogenicity of phytoestrogens
in cells of different estrogen sensitive tissues. Toxicol In Vitro. 2001
Aug-Oct;15(4-5):433-9. PubMed PMID: 11566575.


227: El-Tanani MK, Barraclough R, Wilkinson MC, Rudland PS. Regulatory region of 
metastasis-inducing DNA is the binding site for T cell factor-4. Oncogene. 2001
Mar 29;20(14):1793-7. PubMed PMID: 11313926.


228: Brekelmans CT, Seynaeve C, Bartels CC, Tilanus-Linthorst MM,
Meijers-Heijboer EJ, Crepin CM, van Geel AA, Menke M, Verhoog LC, van den
Ouweland A, Obdeijn IM, Klijn JG; Rotterdam Committee for Medical and Genetic
Counseling. Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation 
carriers and women with high familial risk. J Clin Oncol. 2001 Feb
15;19(4):924-30. PubMed PMID: 11181654.


229: Samudio I, Vyhlidal C, Wang F, Stoner M, Chen I, Kladde M, Barhoumi R,
Burghardt R, Safe S. Transcriptional activation of deoxyribonucleic acid
polymerase alpha gene expression in MCF-7 cells by 17 beta-estradiol.
Endocrinology. 2001 Mar;142(3):1000-8. PubMed PMID: 11181512.


230: Piccart M. Closing remarks and treatment guidelines. Eur J Cancer. 2001
Jan;37 Suppl 1:S30-3. Review. PubMed PMID: 11167089.


231: Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks
JR, Lambers AR, Futreal PA, Stampfer MR, Sukumar S. High frequency of
hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast
cancer. Proc Natl Acad Sci U S A. 2000 May 23;97(11):6049-54. PubMed PMID:
10811911; PubMed Central PMCID: PMC18556.


232: Wang F, Jiang X, Yang DC, Elliott RL, Head JF.
Doxorubicin-gallium-transferrin conjugate overcomes multidrug resistance:
evidence for drug accumulation in the nucleus of drug resistant MCF-7/ADR cells. 
Anticancer Res. 2000 Mar-Apr;20(2A):799-808. PubMed PMID: 10810357.


233: Euhus DM, Maitra A, Wistuba II, Ashfaq R, Alberts A, Gibbons D, Gazdar AF.
Use of archival fine-needle aspirates for the allelotyping of tumors. Cancer.
1999 Dec 25;87(6):372-9. PubMed PMID: 10603191.


234: Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M,
Tsuruoka N, Koeffler HP. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a
unique class of potent inhibitors of proliferation of human prostate, breast and 
myeloid leukemia cell lines. Anticancer Res. 1999 May-Jun;19(3A):1689-97. PubMed 
PMID: 10470102.


235: Engelman JA, Zhang XL, Lisanti MP. Sequence and detailed organization of the
human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation
of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast 
cancer cell lines. FEBS Lett. 1999 Apr 9;448(2-3):221-30. PubMed PMID: 10218480.


236: Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC. Quantitative
polymerase chain reaction for the detection of micrometastases in patients with
breast cancer. J Clin Oncol. 1999 Mar;17(3):870-9. Erratum in: J Clin Oncol 1999 
Apr;17(4):1330. PubMed PMID: 10071278.


237: Gupta M, McDougal A, Safe S. Estrogenic and antiestrogenic activities of
16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human
breast cancer cells. J Steroid Biochem Mol Biol. 1998 Dec;67(5-6):413-9. PubMed
PMID: 10030690.


238: Kononen J, Bubendorf L, Kallioniemi A, Bärlund M, Schraml P, Leighton S,
Torhorst J, Mihatsch MJ, Sauter G, Kallioniemi OP. Tissue microarrays for
high-throughput molecular profiling of tumor specimens. Nat Med. 1998
Jul;4(7):844-7. PubMed PMID: 9662379.


239: Shen KL, Harn HJ, Ho LI, Yu CP, Chiu SC, Lee WH. The extent of proliferative
and apoptotic activity in intraductal and invasive ductal breast carcinomas
detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated
digoxigenin-11-dUTP nick end labeling. Cancer. 1998 Jun 15;82(12):2373-81. PubMed
PMID: 9635530.


240: Emi M, Matsushima M, Katagiri T, Yoshimoto M, Kasumi F, Yokota T, Nakata T, 
Miki Y, Nakamura Y. Multiplex mutation screening of the BRCA1 gene in 1000
Japanese breast cancers. Jpn J Cancer Res. 1998 Jan;89(1):12-6. PubMed PMID:
9510469.


241: Lacroix M, Body JJ. Regulation of c-fos and c-jun expression by calcitonin
in human breast cancer cells. Calcif Tissue Int. 1997 Jun;60(6):513-9. PubMed
PMID: 9164825.


242: Chakraborty R, Little MP, Sankaranarayanan K. Cancer predisposition,
radiosensitivity and the risk of radiation-induced cancers. III. Effects of
incomplete penetrance and dose-dependent radiosensitivity on cancer risks in
populations. Radiat Res. 1997 Mar;147(3):309-20. PubMed PMID: 9052677.


243: Lin JC, Scherer SW, Tougas L, Traverso G, Tsui LC, Andrulis IL, Jothy S,
Park M. Detailed deletion mapping with a refined physical map of 7q31 localizes a
putative tumor suppressor gene for breast cancer in the region of MET. Oncogene. 
1996 Nov 7;13(9):2001-8. PubMed PMID: 8934547.


244: McKinley AG, Russell SE, Spence RA, Odling-Smee W, Nevin NC. Hereditary
breast cancer and linkage analysis to BRCA1. Br J Surg. 1995 Aug;82(8):1086-8.
PubMed PMID: 7648160.


245: Dunbar CE, Cottler-Fox M, O'Shaughnessy JA, Doren S, Carter C, Berenson R,
Brown S, Moen RC, Greenblatt J, Stewart FM, et al. Retrovirally marked
CD34-enriched peripheral blood and bone marrow cells contribute to long-term
engraftment after autologous transplantation. Blood. 1995 Jun 1;85(11):3048-57.
PubMed PMID: 7538814.


246: Abel KJ, Boehnke M, Prahalad M, Ho P, Flejter WL, Watkins M, VanderStoep J, 
Chandrasekharappa SC, Collins FS, Glover TW, et al. A radiation hybrid map of the
BRCA1 region of chromosome 17q12-q21. Genomics. 1993 Sep;17(3):632-41. PubMed
PMID: 8244380.


247: Folkman J, Hanahan D. Switch to the angiogenic phenotype during
tumorigenesis. Princess Takamatsu Symp. 1991;22:339-47. Review. PubMed PMID:
1726933.


248: Jandrig B. Amplification of oncogenes and disease prognosis. Arch
Geschwulstforsch. 1990;60(2):141-8. Review. PubMed PMID: 2187430.


249: Lebel RR, Gallagher WB. Wisconsin consanguinity studies. II: Familial
adenocarcinomatosis. Am J Med Genet. 1989 May;33(1):1-6. PubMed PMID: 2750776.


250: Cowan KH, Goldsmith ME, Levine RM, Aitken SC, Douglass E, Clendeninn N,
Nienhuis AW, Lippman ME. Dihydrofolate reductase gene amplification and possible 
rearrangement in estrogen-responsive methotrexate-resistant human breast cancer
cells. J Biol Chem. 1982 Dec 25;257(24):15079-86. PubMed PMID: 7174686.


251: Strauchen JA, Arya SK, Tralka TS, Engel LW, Young NA. Search for
retrovirus-like particles in human breast cancer cells in culture. Cancer Res.
1980 Nov;40(11):3880-5. PubMed PMID: 6162539.

